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CHAPTER 1 
General introduction and aim of the study 
1.1. Introduction 
In recent years β -adrenoceptor blocking drugs have been frequently used in 
the treatment of hypertension. The development of these drugs was based 
on the adrenoreceptor theory which was introduced in 1948 by Ahlquist. 
The effects induced by sympathetic neurotransmitters and circulating cate­
cholamines may arise via activation of various kinds of receptors. Ahlquist 
distinguished a- and /3-receptors on the grounds of the relationship that he 
demonstrated between the effects and the molecular structure of the cate­
cholamines. Later on the ß-receptors were subdivided by Lands et al. (1967) 
into 2 subgroups, β ι for the cardiac and β2 for the vascular and bronchiolar 
receptors. In table 1.1 an outline is given of the occurrence of these receptors 
in the various organs and tissues and of the response that is to be expected 
after their stimulation. The catecholamines turned out to have varying relative 
affinities for these receptors. The α-receptors responded well to adrenaline 
and noradrenaline and were practically insensitive to isoprenaline (Ahlquist 
1948, Ahlquist 1976). With regard to the /3-receptors it was found that 
adrenaline possessed the highest relative affinity towards the 02 -receptors 
and noradrenaline towards the 0!-receptors, while isoprenaline had a fairly 
similar affinity towards both receptors. (Lands et al. 1967). 
Later studies with selective 0 j - and 02 -receptor blockers have made it plau­
sible that there is no absolute organ separation of the two 0-receptor sub­
types, as had been suggested by Lands et al. Organs and tissues were found 
to possess both 0!- and 02-receptors mediating one and the same response (Carlsson et al. 1972, Ablad et al. 1975, Carlsson and Ablad 1976). So it 
appeared that the heart had mainly 0! - but also 02 -receptors; and the bron­
chus had mainly 02 - but also 0i -receptors, (table 1.1). 
A more physiological subdivision of the adrenoreceptors was recently intro­
duced by Ariens and Simonis (1976). In the adrenergic system there are on 
the one hand receptor sites for noradrenaline, that is the neurotransmitter of 
th sympathetic nerce endings, and, on the other hand, receptor sites for 
adrenaline, a hormone from the adrenal medulla. Adrenoereceptors can be 
divided into receptors for the hormone adrenaline (a H and 0^), and for the 
neurotransmitter noradrenaline ( α
τ
 and 0 T ) . The difference in the 0T- and 
0 H -receptors up to a certain height runs parallel to the empirical difference 
in 0! - and 02 -receptors. Also, the selectivity of the tissues for 0 T and 0 H are 
mostly of relative character (Ariëns and Simonis 1976). 
The antihypertensive effect of 0-blockers was first described in 1964 for 
pronethalol and confirmed for propranolol in the same year (Prichard 1964, 
Prichard and Gillam 1964). Since propranolol had proved to be an effective 
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antihypertensive agent over a long period (Prichard and Gillam 1969, Zacharias 
and Cowen 1970) it has been used more and more frequently in past years, 
and all the more because no orthostatic drop in blood pressure is caused and 
the side effects are few. This led to the production of many new β -blockers 
Table 1.1. 
Distribution of adrenergic receptors in some organs and the responses to 
stimulation 
Organ 
— heart 
— blood vessels in 
skeletal muscle 
and coronary 
vessels 
- blood vessels in 
skin and kidney 
- bronchi 
-- wall of gut 
— sphincters of gut 
— uterus 
kidney 
skeletal muscle 
-- fat tissue 
— pancreas 
Receptor type 
(3, 
ß2 
a 
a 
02 
(02)* 
(0.) 
(01 ) 
a and β ι 
a 
a 
02 
ßl 
02 
02 
01 
α 
02 
(02) 
(02) 
(0.) 
Response 
increase in heart rate 
increase in contractility 
increase in conduction 
increase in excitability 
vasodilatation 
vasoconstriction 
vasoconstriction 
relaxation 
relaxation 
constriction 
increase in contractility 
decrease in contractility 
renin release 
tremor 
glycogenolysis 
lipolysis 
inhibition of insulin 
release 
stimulation of insulin 
release 
* Between brackets, the receptor type occurring in an relatively lower concentration. 
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with pharmacologically different properties for which, on theoretical grounds 
advantages were claimed, which were found in practice to be of little impor-
tance (Bühler et al. 1975, Shanks 1976, Davidson et al. 1976). Propranolol 
continued to be the most used 0-blocking agent for the treatment of hyper-
tension and was frequently used in research on the physiological aspects of 
/3-blockade. In this way propranolol has become the standard /3-blocker, with 
which others are often compared (Brick et al. 1968, Johnsson et al. 1969, 
Bengtsson 1976b). 
Most ß-blockers are, like propranolol, not selective and block both j3i- and 
02 -receptors. A side effect of nonselective j3-blockade that is to be expected 
is bronchial obstruction, which occurs by blockade of the bronchiolar 02 -
receptors (Zacharias et al. 1972). From this point of view the development 
of /}] -selective agents such as practolol, atenolol and metoprolol was an 
advance (Beumer and Hardonk 1972, Johnsson et al. 1975a, Vilsvik and 
Schaanning 1976, Zacharias 1976). Practolol has in the meantime been taken 
off the market after it had been found to cause severe side effects such as 
sclerosing peritonitis and the oculocutaneous syndrome (Brown et al. 1974, 
Hensen et al. 1974, Felix et al. 1974). Metoprolol and atenolol are at the 
present time available for use in medical practice. 
It has been found that both the non-selective and the β ι -selective blockers 
lower blood pressure (Davidson et al. 1976). The mechanism via which the 
blood pressure is lowered has not yet been completely elucidated. But it is 
generally assumed that the lowering of the blood pressure is brought about 
by blockade of /S-receptors and not via other pharmacological properties, 
which these agents may possess, such as a membrane-stabilizing effect, intrin­
sic sympathicomimetic activity or a local anaesthetic effect (Shanks 1976, 
Lewis 1976). Various possible ways of explaining the antihypertensive action 
of ^-blockers have been suggested, such as the effect on the renin-angiotensin 
system; the lowering of the cardiac output; the raising of the sensitivity of 
the baroreceptor reflex; or a possible action via the central nervous system 
(Lewis 1976, Lorimer et al. 1976). 
It is generally known that propranolol and other β -blockers lower the cardiac 
output. After a single dose of propranolol the blood pressure hardly drops at 
all, because, with the fall in the cardiac output, the peripheral resistance 
increases (Tarazi and Dustan 1972, Hansson et al. 1974). The lowering of 
the blood pressure occurs in the course of several weeks and is connected 
with the disappearance of the increase of the total peripheral resistance 
(Hansson et al. 1974). It is not entirely known how this normalization of the 
total peripheral resistance occurs. It seems reasonable to assume that here 
the explanation is by the adaptation of the peripheral circulation to the con­
dition of lowerd cardiac output. Various authors are of the opinion that it is 
the effect of β -blockers on the cardiac output, that is the key to the lowering 
of the blood pressure (Fröhlich et al. 1968, Hanssonet al. 1974, Lewis 1976). 
Another well-known phenomenon is that propranolol lowers the plasma renin 
activity. In some studies during the treatment of hypertensive patients with 
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propranolol a relationship was found between the lowering of the blood 
pressure and the fall of the plasma renin activity (PRA); and also between 
the therapeutic response and the PR A before the treatment (Bühler et al. 
1972, Bühler et al. 1973, Karlberg et al. 1976). With reference to such data 
it is suggested that the antihypertensive effect of propranolol is brought 
about via a lowering of the renin release (Bühler et al. 1975). Also a predic-
tive value is attached to the pretreatment PRA with regard to the hypotensive 
action of propranolol (Bühler et al. 1975, Laragh 1976). But in other studies 
no relationship between the lowering of the blood pressure and the initial 
PRA nor the fall of the PRA during the treatment could be demonstrated 
(Birkenhäger et al. 1971, Hansson et al. 1974, Leonetti et al. 1975, Birken-
häger et al. 1977). Other ß-blockers lowered the blood pressure without 
such a relationship being demonstrable (Stokes et al. 1974, Amery et al. 
1974, Stokes et al. 1976). For these reasons it remains debatable to what 
extent the action of j3-blockers on the PRA is of importance for the lowering 
of blood pressure. 
As at the present time β, -selective blockers are available, it seems reasonable 
to endeavour to find out whether these agents have any advantages over 
propranolol which has been known for so long and used so much. On the 
grounds of theoretical considerations the preference should be given to a 
β ι -selective agent because from it a lesser effect on the vascular 02 -receptors 
is to be expected in comparison with a non-selective ß-blocker. When going 
into this question Johnsson (1975) investigated the haemodynamic effects of 
an adrenaline infusion in healthy test persons, after propranolol or meto-
prolol had been previously given intravenously. Adrenaline infusion after 
administration of propranolol caused a considerable rise of the systolic and 
diastolic blood pressure and an increase of the vascular resistance in the 
forearm. But after metoprolol, adrenaline induced a decrease of the vascular 
resistance in the forearm. Apparently the vasodilating action of adrenaline is 
made impossible by 02 -blockade, so that the α-effect predominates. 
In view of the fact that an endogenous catecholamine release can occur in a 
number of circumstances, such as hypoglycaemias, emotions and physical 
exercise, the observations of Johnsson argue in favour of the use of βι-
selective blockers in the treatment of hypertension. But it is well known that 
the haemodynamic effects of one single dose, as was given by Johnsson, are 
not similar to the effects of long-term medication with β -blockers (Tarazi 
and Dustan 1972, Hansson et al. 1974). I t therefore seems of importance to 
repeat the adrenaline experiments in patients with hypertension, after they 
have been treated for a relatively long time with a β ι -selective, and a non­
selective (З-Ыоскег. 
It is likewise possible that the two kinds of |3-blockers during exercise have 
differing haemodynamic and respiratory effects. The plasma noradrenaline 
and adrenaline levels increase during exercise (Vendsalu 1960) as a sign of 
the increased adrenergic activity, which possibly plays a role in the adapta­
tion of circulation and ventilation (Bevegârd and Shephard 1967, Lefcoe 
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1969). 
The vasodilatation in the active muscle groups that occurs during exercise, 
may possibly be hindered by non-selective blockade, which is not to be 
expected during ^-selective blockade. A different effect on the vasodilata-
tion of both types of 0-blockers would then be of consequence for the blood 
pressure. 
The bronchodilatation that occurs during exercise may be prevented by a 
non-selective ß-Ыоскет, by blockading the bronchiolar j32 -receptors. A 
similar effect is not likely from a β ι -selective agent such as metoprolol 
(Johnsson et al. 1975a). 
A well known side effect of propranolol is the increased fatigue during mus­
cular work (Zacharias 1976). One might ask oneself to what extent this 
phenomenon is connected with the effects on the circulation and respiration 
produced by propranolol during exercise. Possibly insight into this might 
be provided by an investigation into the fatiguebility of excercise during |3-blockade. 
1.2. Aim of the study 
The primary aim was to find out whether treatment with a ßi -selective or a 
non-selective /З-Ыоскег resulted in varying haemodynamic effects during 
states of raised adrenergic activity. As examples of states with raised adrener­
gic activity an infusion of adrenaline (chapter 5) and physical excercise were 
chosen (chapter 6). 
Furthermore we were interested in the question of whether these treatments 
had different effects on the ventilation and the subjective fatiguebility during 
physical exercise (chapter 6). Also this investigation gave an opportunity to 
go into the question of whether there is a connection between the lowering 
of the blood pressure under the influence of both forms of ß-blockade and 
the plasma renin activity (chapter 4). 
In the study of the haemodynamic effects of ^-blockade it was necessary to 
make use of non-invasive measuring procedures in order to avoid emotionally 
stressing stimuli. To study the haemodynamic variables during exercise it was 
therefore of importance to be able to assess the cardiac output in a non-
invasive manner. At the present time various groups of research workers set 
up indirect methods for measuring cardiac output, such as the foreign gas 
method, impedance technique and echocardiography. Research as to the 
validity and reproducibility of these techniques is still far from being com-
plete, moreover an extensive and costly apparatus is required for this pur-
pose. Since the development of rapid CO2 analyzers it has been possible in 
the last 2 decades to measure the cardiac output indirectly according to 
Fick's principle for CO2. A number of the aspects of this relatively simple 
procedure have already been thoroughly investigated. For this reason this 
method for determination of the cardiac output was closely studied and 
adopted (chapters 2 and 3). 
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CHAPTER 2 
The non-invasive determination of the cardiac output during 
exercise according to Pick's principle for CO2 
A study of the literature 
2.1. Pick's formula 
In 1870 Fick introduced a method of calculation by which the cardiac out-
put could be determined. The amount of blood that is pumped through the 
capillary bed of the lungs is calculated by dividing the oxygen uptake by the 
lungs by the increase of the oxygen concentration in that blood. 
Q = ^ (1) 
Ca02 Cv02 
cardiac output 
oxygen uptake by the lungs per minute 
oxygen concentration in the arterial blood 
oxygen concentration in mixed venous blood 
Q 
Vo2 
C a 0 2 
C v O , 
Fick also stated that his method of calculation held good if the correspond-
ing calculation for carbon dioxide gas (C02 ) was made. The flow through 
the pulmonary vascular bed could be measured by dividing the amount of 
expired C02 by the decrease of the C02 concentration that takes place in 
the blood that passes through. 
It was a long time before this principle could be reliably applied for the 
calculation of the cardiac output. The determination of gas concentrations 
in mixed venous blood was the greatest stumbling block and this became 
possible only after catheterization of the pulmonary artery became feasible 
(Forssmann 1929, Klein 1930). This so-called direct Fick method is of a too 
invasive character to be used on test persons for purposes of research. The 
use of a non-invasive technique is more suitable. 
2.2. The indirect application of Fick's principle for C02 
During the last 2 decades the development of rapid and accurate C02 
analyzers has made it possible to determine the C02 tension in arterial and 
mixed venous blood indirectly by means of breathing manoeuvres (Collier 
1956, Defares 1958, Jones et al. 1966). By applying the Fick principle for 
C02 it has now become possible to determine the cardiac output entirely 
non-invasively. As these procedures are not troublesome for test persons, 
they have been instituted and thoroughly studied. 
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As well an indirect technique for O2 has been developed, but this is not 
suitable for routine determinations during effort as in the course of the 
procedure short-lasting severe hypoxaemias occur (Cerretteli et al 1966 b, 
Denison et al. 1969). 
The cardiac output is calculated by applying Fick's formula for CO2 : 
V C 0 2
 V C 0 2 
Q = ^ 2 = = (2) 
C
v C 0 2 -
 C
a C 0 2
 f i ( P T C O ) - U ( P a C O ) 
in which 
Q 
V c 0 2 
С 
C
a C O 
P
vCO 
v C 0 2 
2 
2 
P
a C 0 2 
fj 
f2 
cardiac output 
C 0 2 production per minute 
C 0 2 concentration in mixed venous blood 
C 0 2 concentration in arterial blood 
C 0 2 tension in mixed venous blood 
C 0 2 tension in arterial blood 
function for conversion of P C o into C C o in mixed venous blood 
function for conversion of P
c o
 into C Q Q in arterial blood 
The variables necessary for the calculation are now successively discussed. 
The V c o 2 '
s
 determined by multiplication of the collected expired air per 
unit of time with the C 0 2 gas fraction. 
The РуС02
 c a n
 be determined indirectly by two procedures (Collier 1956, 
Defares 1958). In both methods the test person breathes in and out in a 
closed system, with an anaesthesia bag, that contains a gaseous mixture of 
C 0 2 in 0 2 . This manoeuvre is known as the ' C 0 2 rebreathing' method. The 
C 0 2 tension in this system is continuously recorded with the aid of a rapid 
C 0 2 analyzer. 
In Collier's procedure (1956) the bag has a higher C 0 2 tension than the 
anticipated Русо 2 · During the rebreathing procedure there appears a C 0 2 
plateau lasting for a few seconds as a sign of equilibrium between C 0 2 con­
centrations in the bag, the alveoli and the lung capillaries. Collier stated that 
the C 0 2 tension plateau (Ppiatccb ) ì s m accordance with the Русо · 
During the Defares (1958) procedure the initial C 0 2 tension in the bag is 
lower than the anticipated Русю · During this rebreathing procedure the 
C 0 2 concentration in the bag rises exponentially without an equilibrium 
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plateau being reached. The Русо, *8 estimated by extrapolation. 
The plateau method of Collier is simple and can be carried out without 
extra graphic work. Moreover the observations with the plateau method were 
found to be better reproducible than with the extrapolation method (Godfrey 
and Wolf 1972). For the indirect determination of the Русо > therefore, the 
plateau method of Collier deserves preference. This rebreathing procedure 
will be more extensively discussed in paragraph 2.3. 
At rest the P
a
co 2 *
3
 i*1 practical agreement with the end expiratory C0 2 
tension (PETCOT ) s o ^ a * ^ e ^aCO, i s s i m P l e to approach indirectly (Chen 
and Lyons 1962, Jones et al. 1966). During effort the P
a
co
 a n ( i ^ETCO 
are not in agreement (Asmussen and Nielsen 1956, Jones et al 1966, Kesseler 
1966). The P
a
co 2
 i s
 then calculated via Bohr's formula for the physiological 
dead space, in which values estimated for the dead space are substituted. This 
approach is discussed in paragraph 2.4. 
The function (f) for the conversion of CO2 tension to C0 2 concentration 
can be read off from a C0 2 dissociation curve. Various C0 2 dissociation 
curves are described in the literature. The CO2 dissociation curve is, among 
other things, dependent on the temperature, 0 2 saturation, haemoglobin 
concentration and acid-base balance. In paragraph 2.5. the various C0 2 
dissociation curves and the effects of the various variables are analyzed. 
The cardiac output is calculated by means of Pick's formula. In the applica­
tion of the indirect principle for C0 2 , only the pulmonary capillary flow 
of blood that has participated in the gas exchange is measured. But the 
cardiac output contains as well the so-called shunt blood that comes out of 
the pulmonary artery into the pulmonary vein without having shared in the 
gas exchange. In healthy persons the shunt is limited (average about 3%, 
Mellemgaard 1966) and for that reason is mostly neglected. 
The use of the indirect principle of Fick for CO2 is further limited by the 
fact that for the determination of the cardiac output at rest this method is 
not well reproducible (Clausen et al. 1970, Zeidifard et al. 1972, personal 
observations). At rest the difference between venous and arterial C0 2 con­
centrations is so small that slight errors in their determination cause consider­
able divergencies in the calculation of the cardiac output. Furthermore the 
test person at rest during the collection of the expiratory air has a tendency 
to hyperventilation, so that the Vco2 increases and the cardiac output is 
overestimated. These objections are to a great extent absent during effort 
(Clausen et al. 1970, Zeidifard et al. 1972). 
The determination of the cardiac output by the Fick principle is time-
consuming so that the examination should be carried out during steady-state 
exercise in order to keep the degree of reliability as high as possible. During 
effort changes occur, among other things, in the acid-base balance, which 
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may yield consequences for the CO2 dissociation curve. These aspects of the 
physiology of exercise will be discussed in paragraph 2.6. 
2.3. The indirect determination of the mixed venous C02 tension according 
to the plateau method 
2.3.1. The rebreathingprocedure 
During the rebreathing procedure according to Collier (1956) the test person 
breathes in and out in a closed system, with an anaesthesia bag, that contains 
a gas mixture of CO2 in O2 . As the initial CO2 tension in the bag is chosen 
higher than the anticipated PyCCV the excess of CO2 from the bag flows 
down via the alveoli and lung capillaries. During the continuous recording of 
the CO2 concentration a CO2 plateau may occur, so indicating a complete 
equilibrium between bag, alveoli and lung capillaries. Collier stated that this 
plateau C0 2 tension is equal to the РуС02 · After the plateau the P C o in the 
_ . 
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Figure 2.1. 
Record of P
c o
 during C 0 2 rebreathing procedure according to Collier (1956). A con­
stant P
c o
 is obtained as a sign of equilibration 5 seconds after the start of rebreathing 
(arrow). Thereafter the P
c o
 increases by recirculation. 
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system will again rise, as recirculation causes the venous CO2 tension to 
increase (see paragraph 2.3.2.). Figure 2.1. shows the recording of the C0 2 
tension carried out according to this procedure in a test person during exer­
cise (personal observation). The origination of the plateau and the rise of the 
P C 0 after recirculation are plainly visible. 
2.3.2. The recirculation time 
The recirculation time is the time that the inhaled CO2 requires to reappear 
in the lung capillaries after being carried off via the lung circulation. At rest, 
in the sitting position, the recirculation time averages 13 to 15 seconds 
(Rigatto et al. 1968, Sowton et al. 1968). The recirculation becomes shorter 
as the cardiac output increases and so gradually falls off as the work load at 
the test persons increases (Rigatto et al. 1968). During submaximal exercise 
the recirculation time may regress to an average of 8 to 10 seconds (Jones et 
al. 1967, Rigatto et al. 1968, Sowton et al. 1968). To obtain an equilibrium 
plateau within this short recirculation time, a rapid and deep ventilation is 
required during the rebreathing procedure. Short-lasting hyperventilation of 
gas mixtures with a high CO2 concentration was found to induce no change 
in the cardiac output (McGregor et al. 1962). Good results were obtained at 
rest with a respiration rate of 30 breaths per minute and during exercise 
with a rate of 30 to 60 per minute (Godfrey and Wolf 1972, Paterson and 
Cunningham 1976). 
2.3.3. The interpretation of the СО
г
 recording during the rebreathing 
procedure 
The initial C0 2 tension in the bag must be high enough to afford the alveoli 
sufficient CO2. If the initial CO2 tension is too low, there is a rising curve 
without a horizontal plateau (see figure 2.2.). If there is a too high initial 
CO2 tension, also no plateau is obtained, but a continuously falling curve. 
When no equilibrium plateau is formed the rebreathing procedure must be 
repeated with an appropriate initial CO2 tension in de bag. The correct 
initial C0 2 tension is not entirely foreseeable. The rebreathing procedure can 
be repeated after at least 20 seconds, in view of the excessive CO2 in the body 
that must first be washed out (Jones et al. 1967). The criteria that a good 
plateau must satisfy are according to Ashton and McHardy (1963), Jones et 
al. (1967), Godfrey and Wolf (1972): 
a. the plateau must exist up to the end of the recirculation time. That is 
during exercise, therefore, up to 8 to 10 seconds after the beginning of 
the rebreathing procedure. 
b. The plateau should exist for at least 2 successive breaths or for at least 
2.5 seconds. 
с The slope of the plateau should not amount to more than ± 0 . 5 mm Hg 
per second. 
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When there is a slight slope of a falling or rising CO2 recording curve, the pla­
teau CO2 tension can be estimated via extrapolation (Denison 1967, Jones 
and Rebuck 1973). The line which is drawn through the average CO2 tensions 
after 6 and 10 seconds of rebreathing, approaches in 20 seconds, the plateau 
C0 2 tension (Ppiatco ) within about 1.5 mm Hg (Denison 1967). An example 
of this approach is given in figure 2.2. 
In repeated determinations of the Рр^сОз ^n t e s t persons during steady-state 
exercise, Godfrey and Wolf (1972) found a good reproducibility with a 
variance coefficient of 1.1% and a standard deviation of less than 1 mm Hg 
in an average P^CQ of 71 mm Hg. 
10 mufids 
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Figure 2.2. 
Record of P
c o
 during CO, rebreathing procedure. The P
c o
 rises contineously, because 
the initial P
c o
 in the bag was chosen too low. The plateau P
c o
 was approached via 
extrapolation in 20 seconds according to Denison (1967). Both rebreathing procedures 
(figure 2.1 and figure 2.2) were performed in the same test subject during the same 
steady-state exercise. 
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2.3.4. The alveolocapillary COj tension gradient 
A detailed examination was made of the question of whether the Ppiaico 
during the equilibrating phase of the CO2 rebreathing procedure was in 
agreement with the CO? tension in the blood. Jones et al. (1967) found that 
the Ppiatco w a s greater than the arterial CO2 tension at the same time. In 
view of the fact that the existence of a plateau points to an equilibrium of 
CO2 transport between alveoli and lung capillaries, the presence of a alveolo­
capillary C 0 2 tension gradient (Δ P ^ ^ o ) w a s a remarkable finding. This 
Δ P(A-c)C02 w a s found to exist not only with regard to arterial blood but 
also with regard to mixed venous blood (Denison et al. 1969). The existence 
of a Δ P(A-c)C02 w a s demonstrated in both at rest and during exercise (Jones 
et al. 1969, Godfrey et al. 1971, Jones et al. 1972). 
The rebreathing procedure is normally carried out with a gas mixture of CO2 
in O2 in order to guarantee a sufficient supply of O2. Denison et al. (1969) 
and Jones et al. (1969) went into the question of whether the Δ P(A-C)C02 
was caused by the complete oxygenation of the mixed venous blood in the 
lung capillaries. But also during the rebreathing procedure with a gas mixture 
of CO2 in N2, an alveolocapillary CO2 tension gradient during the plateau 
phase was demonstrated. 
Both Denison et al. (1971) and Jones et al. (1972) showed experimentally 
that there is a relationship between the Р р ^ с о a n ^ the P(A-C)CO · ^ e 
comparison as reported by both groups of workers are in close agreement. 
Denison et al. (1971): Δ P ^ J C O , = 0 . 2 1 P p k t C o 2 - 9 ± 2.47 mm Hg (3) 
Jones et al. (1972): Δ Р(Ач:)СОІ = 0-23Pp l atco2 " Ю · 3 m m H g ( 4 ) 
There is no certain explanation for this alveolocapillary CO2 tension gradient. 
The Δ P(A-c)co ^ w e ^ a s being related to the РріаісОг w a s ^ о и п с І to be like­
wise related to the H+ and HCOJ ion concentrations in the mixed venous 
blood and to the current velocity of the blood along the alveoli (Gurtner et 
al. 1969, Jones et al. 1972). 
According to Gurtner et al. (1969) the Δ Р(А-С)С0 2 т а У be caused by an 
imbalance, such as exists in the blood between CO2 with H+ and H C O j , 
directly at the wall of the lung capillaries. Because of the presence locally of 
undissociated weak acids, this balance shifts towards CO2 , with as consequence 
a higher CO2 tension at the capillary wall and in the alveoli with regard t o 
the blood that flows through the lung capillaries. This notion was derived 
from a theoretical model, in which a CO2 gradient of this kind was found to 
exist over an electrically charged membrane. 
On the other hand it is well known that the equilibration between CO2 with 
H* and HCOi in the blood is a relatively slow process (Forster and Crandall 
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1975). Jones et al. (1972) therefore assumed that especially the raised СО
г 
production in tissues in combination with the short circulation time during 
effort would lead to an incomplete equilibrium in blood between CO2, H+ 
and HCOj. This would than cause a transitory increase of the Рссь ' n 
mixed venous blood, but which would be in equilibrium with the alveolar 
C0 2 tension. In this way then a Δ P(A-C)CO would exist with regard to the 
analysed samples of blood, in which in the meantime a complete equilibra­
tion of C0 2 with H
+
 and HCOJ will have taken place. 
During the rebreathing procedure, therefore, the Ppiatco ^s higher than the 
directly measured P^eo . Moreover the CO2 rebreathing method caused no 
change of the CO2 tension in the mixed venous blood (Denison et al. 1969). 
If the excessively high Ppiatco, ^s u s e c l i n the Fick formula (formula 2), it 
may be expected that the cardiac output will be underestimated. By doing 
comparative studies with other methods for the determination of the cardiac 
output the question may be settled whether the Рр^со should be corrected 
before using it. According to various authors, if uncorrected Ppiatco *8 u s e d 
in the Fick formula for the cardiac output values there is a relatively good 
agreement with the values measured directly (Denison et al. 1969; Godfrey 
et al. 1971; Godfrey and Wolf 1972). On the contrary other investigators 
reported too low cardiac output values with the use of the uncorrected 
PplatCO (Jones et al. 1967; Knowlton and Adams 1974; Paterson and 
Cunningham 1976), while Zeidifard et al. (1972) published low values within 
the normal range. Paterson and Cunningham (1976) established that if the 
^plateo, w a s corrected for the Δ P(A-C)CO the cardiac output values were in 
better agreement with the data in the literature. 
But the various authors employed different standard CO2 dissociation curves 
for the conversion of C0 2 tension into CO2 concentration. A closer analysis 
of these standard C0 2 dissociation curves is called for, before the various 
observations can be compared with each other. We return to this considera­
tion in paragraph 2.5. 
For comparison of repeated examinations in one person it is not of impor­
tance whether the PpiatcOj 1Β·> o r i s η ο ^ corrected, provided the conditions 
for the CO2 dissociation curve remain the same (see paragraph 2.5.). 
2.4. The indirect determination of the arterial CO2 tension 
In the non-invasive determination of the cardiac output, naturally, the P
a
co 
must be determined indirectly. At rest the P
a
co i s i n reasonable agreement 
with the CO2 tension at the end of a normal expiration (PETCO ) (Chen and 
Lyons 1962; Jones et al. 1966). During exercise there are greater differences 
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between the P E T C 0 2
 an
^ ^аСОг · T*16 ^ЕТСОг * s ' ^ a ^ 6 ' higher (up to about 
9 mm Hg), so that an estimation of the P
a
co 2 from the PETCO 7 i
s η ο
^ valid 
(Asmussen and Nielsen 1956; Jones et al. 1966; Kesseler 1966). Another 
method is then necessary for estimation of the P
a
co2 · ^ n g e n e r a l u s e ' 8 made 
of Bohr's formula for the physiological dead space, in which a relationship 
between the P
a
co
 an<
^ other respiratory parameters is given. 
P
aC02
 — PECOi 
VD = VT
 2
- * (5) 
r
aCO, 
VD 
v T 
P E C O 
Ρ 
2 
aCO, 
the physiological dead space 
tidal volume 
CO2 tension in the collected expiratory air 
CO2 tension in arterial blood 
In healthy test persons a relationship between VD and VT during exercise 
was established (Asmussen and Nielsen 1956; Jones et al. 1966). For the 
regression line published by Asmussen and Nielsen that gives the relation 
between VD and V-p, we calculated the following formula: 
1 
VD = V T x — + 0.151 (6) 
(Vj) and VT in litre) 
If now VT and PECO 2
 a r e
 determined, the P
a
co i s calculated from the 
formulas (5) and (6). 
The effect of the range of the VD from the data of Asmussen and Nielsen on 
the calculated P
a
co 2 caused a resultant maximal error of ± 1.7 mm Hg 
(Knowlton and Adams 1974; personal calculations). The observations of 
Jones et al. (1966) with regard to the physiological dead space during exer­
cise are in practical agreement with the data of Asmussen and Nielsen (1956). 
If there are no important aberrations of lung function, the P
a
co during 
effort may be satisfactorily approximated by substitution in Bohr's formula 
estimated values of the physiological dead space. When the P
a
co calculated 
in this way was applied, the cardiac output turned out to be very reliably 
calculated (Godfrey and Davies 1970). 
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2.5. The CO2 dissociation curve 
2.5.1. Introduction 
After the P
a
co
 a n
^ v^CO ' i a v e been determined, these must be converted 
into CO2 concentrations in order to calculate the cardiac output (see formula 
2). For this conversion use can be made of a standard CO2 dissociation curve 
(Christiansen et al. 1914; Comroe et al. 1962), C0 2 dissociation tables 
(McHardy 1967), or a calculation programme (Kelman 1967, Godfrey 1970). 
The question is to what extent the functions f 1 and f2 for the CO2 dissocia­
tion curve from formula (2) are similar, in other words, whether the Русск 
and the P
a
co ^
e o n
 ^
1 6 s a m e
 CO2 dissociation curve. 
The CO2 dissociation curve is dependent on the haemoglobin concentration, 
pH, base excess, temperature and O2 saturation. In the rebreathing proce­
dure use is made of a gas mixture of CO2 of which the O2 constitutes at least 
80% so that it can be relied upon that the PpiatcOi 0 ^ almost completely 
oxygenated mixed venous blood in the lung capillaries is determined (McHardy 
1967; Godfrey 1970). Both the fyco2 a n d t h e PaC02 l i e o n t h e s a m e C 0 2 
dissociation curve for oxygenated blood, so that the functions f! and f2 
from the formula 2 are like each other. In this way the estimation of the 
venoarterial difference in CO2 concentration ( C ^ Q J — ^аСОг ) ^ г о т the 
P
vC02 a n d PaC02 i s simplified. 
2.5.2. CO2 dissociation curves from the literature 
First of all it is necessary to see whether the various CO2 dissociation curves 
that have been published have differing consequences for the application of 
the Fick principle for CO2 . For this purpose we have taken 2 arbitrary situa­
tions during physical work of about 100 W with a constant CO2 production 
and a constant venoarterial CO2 tension difference. This work load means a 
light to moderate effort for normal subjects. In table 2.1. the results for this 
effort are summarized, in which there was assumed a V
c o
 of 1.33 1/min., a 
P
vC02 0 ^ 65 mm Hg, and a PgCOj 0 f 40 mm Hg. In table 2.2. the results are 
given for the same effort with a VCo 2 of 1.33 1/min, а Русо
 0
^ 60 m m Hg 
and P
a
co 2
 0 f 35 mm Hg, as occurring during slight hyperventilation. At the 
same Ру^Ог
 a n d
 ^aCOj ^ 6 v a r ious standard CO2 dissociation curves cause 
obviously differing CO2 concentration gradients so that the calculations of 
the cardiac output can differ by as much as 16%. These differences in the 
CO2 dissociation curves were also reported by Paterson and Cunningham 
(1976). The various publications as summarized in both tables are therefore 
difficult to compare with each other. It is then not surprising of that, for 
instance, Knowlton and Adams (1974) published lower cardiac output values 
than Zeidifard et al (1972). 
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Table 2.1. Effects of various CO, dissociation curves on the venoarterial CO, concentration gradient and the cardiac output 
during moderate exercise with an assumed V
c o
 of 1.33 1/min, a P i c o of 65 mm Hg and a P a C O of 40 mm Hg. 
COj dissociation curve Employed by 
Klausen et al. 1965 
Clausen et al. 1970 
Knowlton and Adams 1974 
Jones et al. 1967 
Godfrey et al. 1971 
Godfrey and Wolf 1972 
Paterson and 
Cunningham 1976 
C
v C O , 
(ml/100 
10.0 
10.5 
9.5 
C
a C O , 
ml) 
Q 
(l/min) 
13.3 
12.7 
14.0 
( A Q ) 
(%) 
(+5) 
(0) 
(+9) 
S* 
0.37 
0.44 
0.38 
Christiansen et al. 1914 
Comroe et al. 1962 
McHardy 1967 
Godfrey 1970 Zeidifard et al. 1972 10.1 13.2 (+4) 0.40 
* For S see paragraph 2.5.3. 
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Table 2.2. Effects of various C 0 2 dissociation curves on the venoarterial CO, concentra­
tion gradient and the cardiac output during moderate exercise with an assumed V C Q of 
1.33 l/min, a P ^ o of 60 mm Hg and a P
a C O of 35 mm Hg. 
CO, dissociation curve 
^ СО, ^aCO, 
(ml/100 ml) 
Q 
(1/min) 
12.8 
11.6 
13.0 
13.4 
( A Q ) 
(%) 
(+10) 
(0) 
(+12) 
(+16) 
s* 
0.37 
0.42 
0.38 
0.40 
Christiansen et al. 1914 10.4 
Comroe et al. 1962 11.5 
McHardy 1967 10.2 
Godfrey 1970 9.9 
* for S see paragraph 2.5.3. 
2.5.3. Influences on the C0 2 dissociation curve 
The evaluation of the various influences on the C0 2 dissociation curve, 
such as temperature, 0 2 saturation, haemoglobin concentration, and acid-
base balance, is possible by means of a calculation programme, as published 
by Kelman (1967) and Godfrey (1970). 
The effect of the temperature of blood on the C0 2 dissociation curve was 
calculated by means of Kelman's computer programme. The calculation was 
also done for an arbitrarily chosen situation during moderate effort with a 
V C o 2 of 1.33 1/min., P^co^ of 65 mm Hg and P a C 0 2 of 40 mm Hg. In the 
computer programme there are given: a pH
a
 of 7.40; pH^ of 7.27 and a 
haematocrit of 0.45 1/1. The calculated venoarterial CO2 concentration 
gradient falls off with rising temperature, but only very slightly (see table 2.3.). 
During effort lasting about 10 minutes the increase of temperature is maxi­
mally 10C (Harris and Porter 1958), so that a correction for the temperature 
rise in theC02 dissociation curve during effort can be neglected in the calcula­
tion of the cardiac output (see table 2.3.). 
In the study of the influences of 0 2 saturation, acid-base balance and haemo­
globin concentration the simpler programme of calculation of Godfrey was 
employed. This calculation programme was not used in order to study the 
effect of the temperature on the C0 2 dissociation curve as it does not cover 
the case of the influence of temperature. Godfrey based his programme on 
Visser's equations (1960) and the modifications suggested by McHardy 
(1967). The C0 2 concentration in whole blood in vitro is approached with 
the formula: 
C C 0 2 (blood) - C C 0 2 (plasma) ( l - k i x k 2 x к з ) (7) 
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Table 2.3. Effect of the temperature on the venoarterial CO
a
 concen­
tration gradient and the cardiac output during moderate exercise with 
an assumed V
c o
 of 1.33 l/min, а Русо of 65 mm Hg and a P t t C O of 
40 mm Hg. 
Temperature 
ГО 
37 
38 
39 
C
v C 0 2 (ml/100 
11.09 
11.04 
10.80 
C
a C 0 1 
ml) 
Q 
(l/min) 
11.99 
12.05 
12.31 
(%) 
(0) 
(+0.5) 
(+3) 
The factors k!, k2 and кз depend respectively on the haemoglobin concen­
tration, O2 saturation and pH: 
k, = 0.0465 Hb (Hb in mmol/1) 
1 
ki = (SO2 : О, saturation in fraction) 
2.244-0.422 S0 2 
1 
k3 = 8 . 7 4 - p H 
The C0 2 concentration in the plasma can be approximated with the formula 
of Henderson and Hasselbalch: 
pH = 6.10 +log -
CcO, (plasma) 1 ] 
L»; i _ 0.0307 ρ ) L (8) 
2.226 ο υ 2 0.0307.PC O f 
2.226 
0.0307 
6.10 
is the conversion factor for maeq/1 to ml/100 ml 
is the solubility coefficient of CO2 in plasma 
is the pk value 
From the equations (7) and (8) the concentration for full blood is deduced. 
Cco 2 (blood) - 2.226 χ 0.0307 P C 0 2 (1+10(PH-Pk)) 
χ (1.0-k, χ k 2 x k j ) (9) 
Furthermore Godfrey (1970) has pointed out that the C0 2 dissociation curve 
in its logarithmic form is almost a straight line (Siggaard-Andersen 1963). In 
view of the fact that the P C o of oxygenated mixed venous blood lies on the 
same dissociation curve as the P
a
co 2 ^
 т а
У be stated that: 
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log C
v
-C 0 2 - log C a C o 2 = S (log Ρ ^ θ 2 - log P a C o 2 ) (10) 
S: shows the slope of this straight line. 
From the equations (10) the venoarterial C0 2 content gradient can be 
deduced: 
f p v C 0 2 ì 
CvC02 - CaC02 = CaC02 ho( lo6"^ ) x S - 1 > (11) 
I FaC02 J 
From the equations (9) and (11) together there can be calculated the conver-
sion of the Ptc02 a n d PaC02 i n t o t h e CvC02 — CaC02· 
C ^ o 2 - C a C o 2 =2.226 χ 0.0307 χ P a C o 2 (І+ЮРН-б-Ю) 
f Р С02 
χ ( 1 - к 1 х к 2 х к з ) х j l 0 ( l o g ^ 7 ) x s - l r
a C 0 2 
(12) 
With the aid of the Siggaard-Andersen nomogram (1963) Godfrey (1970) 
calculated the effects of base excess and haemoglobin concentration on the 
slope S: 
1.0 
S = 0.0227 (9.3-Hb) (Hb in mmol/1) (13) 
2.5 + (BE χ 0.0469) 
If BE = 0 and Hb = 9.3 mmol/1 S becomes 0.40. 
We calculated the S for the various C0 2 dissociation curves from the litera­
ture. That not all C0 2 dissociation curves have the same slope S could be 
also seen in the tables 2.1. and 2.2. 
For a healthy test person at rest we can assume: Hb concentration 9.5 
mmol/1, O2 saturation 0.95, pH 7.4, base excess 0. Under these conditions 
Godfrey's equation (formula 12) can be expressed in its simplest form as 
follows: 
Í P vC0 2 ·, 
CvC02 - Caco2 = 1-176 P a C 0 2 j l O 1 0 ^ ^ ) x 0 · 4 - i f (14) 
The above formulas have been deduced from data on the C02 dissociation 
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Table 2.4. Effects of haemoglobin concentration, 0 2 saturation, pH and base excess (BE) on the venoarterial CO, concentra­
tion gradient and the cardiac output during moderate exercise with an assumed V^o 0 ^ 1-33 1/min and arteriovenous CO, 
tension gradient of 25 mm Hg. 
co 
haemoglobin 
(mmol/1) 
0 2 saturation 
(%) 
10.5 
9.5 
8.5 
7.5 
100 
95 
90 
85 
metabolic acidosis 
without respiratory 
compensation 
metabolic acidosis 
with respiratory 
compensation 
P
a C O j 
(mm Hg) 
40 
40 
40 
40 
40 
40 
40 
40 
40 
40 
40 
40 
40 
40 
35 
30 
25 
21 
pH 
7.4 
7.4 
7.4 
7.4 
7.4 
7.4 
7.4 
7.4 
7.4 
7.365 
7.32 
7.29 
7.24 
7.4 
7.4 
7.4 
7.4 
7.4 
BE 
(maeq./l) 
0 
0 
0 
0 
0 
0 
0 
0 
0 
- 2 . 5 
- 5 
- 7 . 5 
- 1 0 
0 
- 2 . 5 
- 5 
- 7 . 5 
- 1 0 
(ml/100 ml) 
9.94 
10.06 
10.26 
10.43 
10.05 
10.06 
10.10 
10.13 
10.08 
9.90 
9.55 
9.53 
9.17 
10.08 
10.45 
10.80 
11.18 
11.62 
(1/min) 
13.38 
13.19 
12.96 
12.75 
13.23 
13.19 
13.17 
13.13 
13.19 
13.43 
13.93 
13.96 
14.50 
13.19 
12.73 
12.31 
11.90 
11.45 
(AQ) 
(%) 
(+1) 
(0) 
(-2) 
(-3) 
(+0.3) 
(0) 
(-0.2) 
(-0.5) 
(0) 
( + 1.8) 
(+5.5) 
(+5.8) 
(+9.9) 
(0) 
(-3.5) 
(-6.1) 
(-9.8) 
(-13.2) 
Remarks 
0 2 saturation: 95% 
haemoglobin: 9.5 mmol/1 
О, saturation: 95% 
haemoglobin: 9.5 mmol/1 
pH and BE derived 
from the Siggaard-
Andersen nomogram (1963) 
0 2 saturation: 95% 
haemoglobin: 9.5 mmol/1 
pH and BE derived 
from the Siggaard-
Andersen nomogram (1963) 
curve for whole blood in vitro. With direct measurements of the C02 concen-
trations and C02 tensions in arterial and mixed venous blood during exercise 
Denison et al. (1971) showed that the measured values lay on the CO2 
dissociation curve for oxygenated blood in vitro, if this was corrected for the 
base excess. This means, therefore, that these formulas may be applied for 
the calculation of the CO2 concentration in blood during exercise. 
It can now be demonstrated what the influences of the different variables are 
on the conversion of C02 tension to CO2 concentration and what conse-
quences ensue for the calculation of the cardiac output according to Fick 
principle for COj . With the formulas (12) and (13) we calculated the effect 
on the venoarterial C02 concentration gradient and the cardiac output of 
changes in arterial blood of the haemoglobin concentration, 0 2 saturation, 
pH and base excess. The calculations were done for an arbitrarily chosen 
situation during moderate effort with a Vco2 0^ 1-331/min and a venoarterial 
C02 tension gradient of 25 mm Hg (table 2.4.) 
A change in the haemoglobin content causes a slight systematic change in the 
calculation of the C02 concentrations and the cardiac output. A change of 
the O2 saturation also has only a slight effect. But changes in the acid-base 
balance can cause greater errors in the calculation of the C02 concentrations. 
The data of table 2.4. suggest, like the observations of Denison et al. (1971), 
that a calculation programme for the C02 dissociation curve must take into 
account the changes in the acid-base balance that occur during exercise. It is 
necessary to gain insight into the changes of 0 2 saturation and acid-base 
balance that occur during exercise for checking up on the abovementioned 
considerations. 
2.6. Physiological aspects of exercise 
2.6.1. Steady-state exercise 
The measurements that are made to determine the cardiac output indirectly 
by the Fick principle require time for collecting the expired air and for 
carrying out the rebreathing procedure. For this reason, in order to carry out 
reliable observations the determinations must be done during steady-state 
conditions. During muscular work, under not too heavy and continuous load, 
a steady-state phase follows upon a period of adaptation. Under heavy work 
load the test person soon becomes exhausted, without a steady-state being 
reached (Harris and Porter 1958). The duration of the initial adaptation 
period is dependent on the heaviness of the work load, but normally does 
not last more than 4 minutes (Harris and Porter 1958, Abelin 1960, Cerretelli 
et al. 1966a). During the steady-state phase the circulatory and respiratory 
parameters remain fairly constant (Harris and Porter 1958, Abelin 1960, Barr 
et al. 1964, Ekelund 1967). During this phase of exercise the energy is almost 
completely supplied by the aerobic metabolism, so that the anomalies that 
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occur in the acid-base balance, especially because of the formation of lac-
tates during the adaptation period, remain stationary (Abelin 1960, Barr et 
al. 1964, Hermaneen and Stensvold 1972). Moreover during a biological 
process only a relative steady-state exists, as the physiological variables are 
prone to slight fluctuations (Lukin 1963). 
2.6.2. Metabolic aspects of exercise 
During muscular work the acid-base balance may change, because the muscle 
cell in particular forms lactic acid as an end product of the anaerobic meta-
bolism. As well as lactic acid, other acids such as pyruvic acid and ketones 
exert an influence on the acid-base balance, but to a much less degree 
(Bouhuys et al. 1966). The quantity of lactic acid that is produced, depends 
on the intensity of the effort, the duration and type of exercise and on the 
condition of the test person (De Coster et al. 1969, Hermansen and Stensvold 
1972). During the phase of adaptation there is a rapid rise of the lactate level, 
after which it drops slightly during the steady-state phase or remains constant 
(De Coster et al. 1969, Hermansen and Stensvold 1972). The lactic acid level 
in arterial blood is related to the physiological load on the subject. For exer-
cise on the bicycle ergometer the following values hold approximately valid. 
During light exercise up to a heart rate of about 120/min the lactate level 
remains limited to about 2 mmol/1. During moderately heavy exercise up to 
a heart rate of about 160/min, the lactate level increases to about 4 mmol/1. 
During the heavier and exhausing exercise there is a more powerful rise of 
the lactic acid level, up to about 10 mmol/1 (Wells et al. 1957), Hermansen 
and Stensvold 1972). During light and moderately heavy exercise the pH 
shows only a slight tendency to fall (to about 7.35), because the increase of 
the ventilation apparently to some extent compensates for this increased 
metabolic load (Barr et al. 1964, Doll et al. 1966). During heavier and maxi-
mal exercise, however, the pH may drop very considerably (to about 7.20) 
(Bouhuys et al. 1966). 
2.6.3. Consequences for the application of the indirect Fick principle for C02 
In determining the cardiac output by the indirect Fick principle for CO2 one 
has to obtain observations that can be satisfactorily reproduced; to do this 
the examination must be made during the steady-state phase of exercise that 
is not exhausting. 
As during submaximal exercise only a limited lowering of the 0 2 saturation 
occurs in arterial blood (Doll et al. 1966), this variable need not to be taken 
into account in the calculation programme for the CO2 dissociation curve 
(see table 2.4.). 
During light and moderately heavy exercise a limited metabolic acidification 
occurs, while the pH, because of the hyperventilation, shows only a slight 
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Table 2 5 ElTects οΓ changes m acid base balance on the venoarterial CO concentration gradient and the cardiac output during exercise under various loads pH, 
base excess and P
a
co
 a r e
 d o n v e d from the publication of Doll et al (1966) concerning bicycle exercise of untrained test subjects Values are chosen for Р
 С О
 and 
V C Q Haemoglobin concentration and O, saturation are fixed on 9 5 mmol/1 and 93% respectively C v C O — C a C 0 are calculated in 3 ways (1) Via formulas 12 and 
13, in which measured pH and base excess were substituted, (2) via formula 14, in which pH is 7 4 and base excess is 0 and (3) via formulas 12 and 13, in which pH 
and base-excess are fixed on 7 4 and —2 5 maeq /1 respectively In accordance with this the cardiac output was calculated three limes and compared with the first 
values 
load 
(W) 
50 
100 
150 
200 
Vco, 
(1/min) 
0 8 
1 3 
1 8 
2 3 
PvCO, 
(mm Hg) 
-)8 
61 
64 
65 
^aCO, 
(mm Hg) 
38 
36 
34 
30 
pH 
7 41 
7 42 
7 38 
7 31 
base 
excess 
(maeq/l) 
0 
- 1 
- 3 
- 1 0 
(1) 
CvCO, - C
a C O j 
(ml/100 ml) 
8 37 
10 58 
11 63 
13 81 
Q, 
(l/min) 
9 56 
12 28 
15 17 
16 66 
CvCO, C a C O ¡ 
(ml/100 ml) 
8 18 
9 99 
11 51 
12 78 
(2) 
(l/mm) 
9 78 
13 01 
15 63 
17 99 
(¿ Q) 
(%) 
( + 2) 
(+6) 
( + 1) 
(+8) 
Cyco, C a C O ¡ 
(ml/mm) 
8 67 
10 47 
12 12 
13 53 
(3) 
(l/min) 
9 23 
12 41 
14 84 
17 00 
( ¿ Q ) 
(%) 
( - 3 5) 
( + 1) 
( - 4 ) 
( •2) 
tendency to fall (Barr et al. 1964, Doll et al. 1966). It makes sense to see to 
what degree changes in the acid-base balance during the effort exert an influ­
ence on the CO2 dissociation curve (see table 2.4.). 
For this purpose the effects of change in pH and base excess on the veno­
arterial CO2 concentration gradient and cardiac output were calculated by us 
during 4 various work loads (see table 2.5.). If the pH was 7.4 and the base 
excess nil, this caused an overestimation of the cardiac output of up to 
about 8% (see 2 in table 2.5.). As there are no data available as to the pH and 
base excess in a complete indirect measurement, the choice was made, on 
the grounds of the data in the literature with regard to moderate effort, of 
a pH of 7.4 and a base excess of —2 5 mmol/1 (Barr et al. 1964, Doll et al. 
1966). If these values are used in the calculation programme for the CO2 
dissociation, the cardiac output can be reasonable approximated between 
—4 and +2% (see 3 in table 2.5.). Because of this it may be concluded that 
an indirect approach to the (C^QQ — С
аСО
 ) is possible from Р^сОг a n <^ 
P
a C 0 , by making a correction for the base excess of —2.5 maeq/1 in the 
calculation programme of Godfrey (1970) formulas 12 and 13). The formula 
for the C0 2 dissociation is then: 
r
 P
v C 0 2 ì 
CvC02 - C a C 0 2 =1.176 χ P a Co 2 V
0 0
^ ? ^ " ' Ι ( 1 5 ) 
In this there are taken for arterial blood: haemoglobin concentration 9.5 
mmol/1, 0 2 saturation 95%, pH 7.4, base excess —2.5 maeq/1. 
Our conclusion with regard to the CO2 dissociation curve during effort is in 
agreement with the direct observations of CO2 concentrations and CO2 
tensions of Demson et al. (1971). 
2.7. Summary 
The indirect determination of the cardiac output by the Fick principle for 
CO2 during effort has become possible in the last 2 decades as, since the 
development of rapid and accurate CO2 analyzers, the CO2 tensions of arte­
rial and mixed venous blood can be indirectly assessed by breathing ma­
noeuvres (paragraph 2.2.). 
The determination of the mixed venous CO2 tension via the CO2 rebreathing 
procedure by Collier's plateau method has been examined in detail and has 
been found to be satisfactorily reproducible (paragraph 2.3.). This CO2 
rebreathing procedure caused no change of the cardiac output nor of the 
mixed venous CO2 tension (P^QQ ). But it was shown that the measured 
plateau of CO2 tension was higher than the simultaneously directly measured 
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CO2 tension in blood. There is no sure explanation forthcoming for this 
alveolocapillary CO2 tension gradient during the plateau phase of the CO2 
rebreathing procedure, so that a discussion exists as to whether a Ppiatco, o r 
a P^co has to be applied in Fick's principle (paragraph 2.3.). 
The arterial C 0 2 tension (P aco ) c a n be indirectly approached by substitu-
tion in the formula of Bohr estimated values for the physiological dead space 
(paragraph 2.4.). 2.4.). 
The CO2 concentrations, which must be filled in Fick's formula, can be 
obtained from the CO2 tensions via a standard CO2 dissociation curve, CO2 
dissociation table or calculation programme (paragraph 2.5.). As, during the 
CO2 rebreathing the CO2 plateau is obtained from almost completely oxy-
genated mixed venous blood, both the P^CQ a n ^ ^ e ^aCCb ^ e o n ^ 6 same 
dissociation curve for oxygenated blood which has simplified the estimation 
of the venoarterial CO2 concentration gradient. From our calculations it has 
turned out that the various CO2 dissociation curves differ from each other to 
such a degree that considerable divergencies exist in the calculation of the 
cardiac output. By applying a calculation programme for the CO2 dissocia-
tion curve, we were able to work out the effects of changes of temperature, 
O2 saturation, haemoglobin concentration and acid-base balance on the veno-
arterial CO2 concentration gradient and on the cardiac output. After, on the 
basis of the data in the literature, scrutinizing the extent to which these 
parameters change during exercise, it seemed desirable for the conversion of 
CO2 tension to CO2 concentration to make use of a calculation programme 
in which corrections are made for the expected changes of pH and base 
excess during effort (paragraph 2.6.). 
To obtain satisfactory reproducible cardiac output values, the measurements 
should be made during steady-state exercise (paragraph 2.6.). 
The indirect determination of the cardiac output by the Fick principle for 
CO2 was found to be satisfactorily reproducible during exercise (Zeidifard 
et al. 1972). 
Before using this cardiac output determination for research purposes it is 
desirable to be quite sure of the reproducibility and to examine what influ-
ence the alveolocapillary CO2 tension gradient in our hands might have on 
this determination (see Chapter 3). 
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CHAPTER 3 
Description of the determination of the cardiac output during 
exercise by the indirect principle of Fick for CO2 
— the validity and reproducibility 
3.1. Introduction 
Before the non-invasive determination of the cardiac output by the indirect 
principle of Fick for CO2 as discussed in Chapter 2, can be used for studying 
the effects of /3-blockers, it is necessary to check the validity and reproduci­
bility of the method. 
In this method in Pick's formula CO2 concentrations are substituted which 
have been obtained via the C0 2 dissociation curve from indirectly measured 
CO2 tensions (paragraph 2.2.). The CO2 tension of mixed venous blood is 
approached via the CO2 rebreathing procedure by the plateau method of 
Collier (1956). However, it was found that the CO2 tension of the plateau 
(PplatCO ) comes out higher than the directly measured CO2 tension in mixed 
venous blood (PyCCK ) (paragraph 2.3.4.). The P^co *3 calculable by subtract­
ing the alveolocapillary CO2 tension gradient (AP(A-C)CO ) from the Ppiatco · 
There is a lack of unanimity in the literature as to whether in the calculation 
of the cardiac output, the Рр^сОг o r ^ e P^co should be used. 
This discussion is made difficult by the fact that the various authors obtain 
the CO2 concentrations in blood from the CO2 tensions via differing CO2 
dissociation curves, which have proved not to be equivalent (paragraph 2.5.2.). 
Moreover we have calculated that the changes in the acid-base balance that 
occur during exercise have such an influence on the CO2 dissociation curve 
that the CO2 concentration is best approached via a calculation programme, 
in which corrections are made for pH and base excess (paragraph 2.5.3. and 
2.6.3.). 
The following aspects of this cardiac output determination are, therefore, 
investigated. 
The aim was to find out whether, f or a valid calculation of the cardiac output, 
the PpiatcOi o r the P<FC02 should be used. As we found it not justified to 
use invasive measurements on test subjects the validity was investigated by 
comparing the results with the data in the literature. 
Also investigated was the question of whether the accepted values for pH 
and base excess in the calculation programme for the CO2 dissociation curve 
were adequate, by collecting blood from a number of test subjects for exam­
ination of the acid-base balance. 
The reproducibility was explored by calculating the standard error of a single 
observation on repeating the measuring after at least 5 days. 
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3.2. Subjects and methods 
3.2.1. Subjects 
The subjects consisted of 16 young men whose ages ranged from 19 to 39 
years and who had a healthy history. The anthropometric data are summarized 
in table 3.1. 
Table 3.1. Individual anthropometric data of the subjects. 
Subject 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
Age 
(yr) 
29 
19 
39 
26 
31 
24 
26 
26 
28 
28 
23 
24 
23 
24 
24 
25 
Height 
(m) 
1.75 
1.80 
1.81 
1.70 
1.87 
1.74 
1.83 
1.79 
1.73 
1.76 
1.72 
1.81 
1.60 
1.87 
1.86 
1.70 
Weight 
(kg) 
74 
73 
76 
63 
93 
72 
78 
65 
54 
58 
68 
77 
59 
68 
74 
54 
3.2.2. Exercise test 
The exercise test was carried out in the morning hours from 09.00 hours on, 
in a room at constant temperature of 19CC. The subjects were asked to take 
only a light breakfast without coffee and not to smoke before the test. After 
resting for half an hour the exercise test was begun. In most of the subjects a 
second exercise test was done on the same morning, with a greater load, and 
once more after at least half an hour of rest. Physical effort was done in a 
sitting position on a bicycle ergometer (Lode) at a pedalling rate of about 
60 cycles per minute. The load was built up within 2 minutes and thereafter 
kept constant. The amount of the load chosen was about 1, 1.5, or 2 watts/kg 
body weight. After 7 minutes of effort a start was made with the measure-
ments during the steady-state phase. Throughout the whole of the exercise 
test the heart rate was recorded electrocardiographically every minute. 
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3.2.3. Measurements of respiratory and haemodynamic variables 
3.2.3.1. The CO2 production (VCo2 ) and the O2 consumption (Vo2 ) 
First of all the expiration air was collected for about 2 minutes in a Douglas 
bag. Simultaneously a portion of the expiratory air with a constant flow of 
1200 ml/min was led through a rapid infra-red C02 analyzer (Capnograph 
Godart type MO) for the continuous CO2 recording during the breathing. 
The signal of the capnograph was written on a recorder (Allcoscript EN 28) 
and a storage oscilloscope (Textronix 5103 N). From the writing on the 
recorder the respiration rate was read off. The volume of the expired air in 
the Douglas bag was determined and the tidal volume was calculated in BTPS. 
The tidal volume (VT) was calculated by dividing the respiratory minute 
volume by the respiratory rate. The expired air that had been collected was 
analyzed in dry gas fraction of CO2 (Uras) and O2 (Servomex. OA 272), 
after which the CO2 production (VCo2) and O2 consumption (VQ ) were 
calculated under STPD conditions in 1/min. Via the CO2 fraction measured 
in the expiratory air the CO2 tension in the expiratory air (PECO ) ^s calcu-
lated by multiplying this fraction by the barometric pressure minus the 
pressure of HjO vapour at 37°C (PB—47 mm Hg). 
3.2.3.2. The CO2 tension in arterial blood 
The physiological dead space (VD) was calculated from the tidal volume via 
the formula which is calculated from the data of Asmussen and Nielsen 
(1956) (formula 6, paragraph 2.4.). 
The arterial CO2 tension (PacOj ) c a r i n o w ^6 calculated from Bohr's formula 
(formula 5, paragraph 2.4.) in which the sum of the VD and the dead space 
of the respiratory apparatus (80 ml) was subtituted for the physiological 
dead space. 
3.2.3.3. The CO2 tension in mixed venous blood 
Following on the collection of the expiratory air the rebreathing procedure 
of Collier (1956) was done. After a maximal expiration the subject rebreathed 
in a closed system with a 5 liter anaesthesia bag which contained a gaseous 
mixture of CO2 in O2 with a CO2 percentage of between 9 and 13%. The 
rebreathing was done at a respiratory rate of 50/min. for 10 to 15 seconds. 
During this procedure the CO2 concentration in the bag was continually 
analyzed and recorded on the storage oscilloscope. If no plateau was obtained 
the rebreathing procedure was repeated after about 30 seconds with an 
appropriate initial CO2 tension in the bag. The equilibration plateau had to 
satisfy the criteria laid down (see paragraph 2.3.3.). The plateau had to exist 
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for at least 2 breaths up to the end of the recirculation time and the slope 
should for preference not amount to more than 0.5 mm Hg/sec. The gradua­
tion of the C0 2 recording on the oscilloscope was such that 1 mm corres­
ponded with 0.4 mm Hg. When there was a slight slope of the plateau the 
PplatCO w a s obtained via Denison's extrapolation (1967) (see paragraph 
2.3.3.)2 
By passing calibration gases with known CO2 in 0 2 gas mixtures, after satura­
tion with H2O vapour, through the capnograph, calibration lines are recorded 
on the storage oscilloscope. By means of these calibration lines the CO2 
concentration of the plateau can be calculated and after multiplication by 
P B - 4 7 (mm Hg), the Рр Ы со 2 · 
The mixed venous CO2 tension (РуссО w a s obtained by subtracting from 
the Ppiatcc^ ^ 6 alveolocapillary CO2 tension gradient (АР(д.с)сС)2) ^ i c h 
was calculated by the method of Jones et al. (1972) (formula 4, paragraph 
2.3.4.). 
3.2.3.4. The venoarterial CO2 concentration gradient 
The venoarterial CO2 tension differences in the blood were calculated from 
the CO2 tensions by the calculation programme of Godfrey (1970), while 
applying a correction for base excess: 
P
v C 0 2 
CV-CO2 - CaC02 = 1-176 P
a C o 2 ( l 0 ( , O g ^ 7 ) X 0 · 4 2 - 1) d 5 ) 
In this formula for arterial blood from healthy subjects during moderate 
exercise there is assumed: Hb: 9.5 mmol/1; pH: 7.4; O2 saturation: 0.95; 
base excess: —2.5 maeq/1 (Barr et al. 1964, Doll et al. 1966) (see paragraph 
2.6.3.). 
3.2.3.5. The cardiac output 
The cardiac output (Q) was calculated by the Fick formula, by dividing the 
VCo by the venoarterial C0 2 concentration difference. The cardiac output 
was calculated in two ways: via the PpiatcOî (Qplat) an^ ™ ^ е PvC02 (Qv)· 
3.2.4. The measurement of the acid-base balance during exercise 
The acid-base balance of the blood of 6 subjects was examined during exer­
cise. For this purpose arterialized venous blood was obtained from a vein on 
the dorsal aspect of the hand for blood gas analysis, use being made of an 
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airtight heparinized glass syringe (Corning Bloodgas 165). To obtain arteria-
lized venous blood the whole hand was soaked for at least half an hour in 
warm water at a temperature of about 45 0 C. The blood was drawn during 
the exercise period immediately before the rebreathing procedure. According 
t o Forster et al. (1972) the pH and base excess in such arterialized venous 
blood constitute a reasonable approximation to arterial values. By substitut­
ing the pH and base excess so measured in the calculation programme of 
Godfrey (1970) for the CO2 dissociation curve, the venoarterial CO2 
concentration difference was calculated from the P^CQ a n ^ ^aCO a n d 
applied to the calculation of the cardiac output (Q*) . The Q* calculated in 
this way was compared with the Qv which had been calculated by applying 
the formula 15 for the CO2 dissociation curve. 
3.2.5. The assessment of the reproducibility 
In 10 subjects the measuring procedure during the same exercise load was 
r repeated at least 5 days afterwards in order t o be able to calculate the 
standard error of a single observation of a number of variables. The standard 
error of a single observation (SE X ) is: 
V ' Σ (Xi j -Xai ) 2 ' i=li-V^ (16) 
Xji : 1st test of subject i 
Х2І '• 2nd test of subject i 
η : number of paired observations 
The relative SEX is obtained by dividing the SEX by the mean of the observa­
tions. 
3.3. Results 
3.3.1. The results of the investigation on the validity 
Altogether 50 exercise tests were carried out in 16 subjects. The parameters 
measured and calculated are summarized in table 3.2. The P ^ o *8 o n ^ 1 6 
average 10% lower than the Ppiatco, · ^ s regards the C 0 2 concentration 
gradients (С
рЫС
о2 — C a C o 2 ) is on the average 17% greater than the 
(CyCO — C
a
c o 2 ) s o that the Qpiat becomes 17% lower than the Qy-
For the relation between the cardiac output and the oxygen consumption 
during exercise the following regression lines were calculated: 
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Table 3 2 Respiratory and haemodynamic variables during exercise 
Subject 
1 
1 
1 
1 
2 
2 
2 
2 
2 
2 
2 
2 
3 
3 
3 
3 
4 
4 
4 
4 
5 
5 
5 
5 
6 
6 
6 
6 
7 
7 
8 
8 
9 
9 
10 
10 
10 
10 
11 
11 
12 
12 
13 
13 
14 
14 
15 
15 
16 
16 
Mean 
date 
16 01 76 
1601 76 
06 02 76 
06 02 76 
20 01 76 
20 01 76 
27 01 76 
27 01 76 
09 01 76 
09 04 76 
21 1076 
21 10 76 
19 01 76 
19 01 76 
26 01 76 
26 01 76 
07 01 76 
07 01 76 
12 01 76 
12 01 76 
08 01 76 
08 01 76 
15 01 76 
15 01 76 
02 01 76 
02 01 76 
13 01 76 
1301 76 
17 1275 
22 12 75 
161275 
23 12 75 
18 1275 
29 12 75 
20 04 76 
20 04 76 
11 05 76 
11 05 76 
25 11 76 
25 11 76 
23 11 76 
27 U 76 
15 04 76 
15 04 76 
25 10 76 
25 10 76 
07 09 76 
07 09 76 
22 10 76 
22 10 76 
work 
load 
(W) 
75 
110 
75 
110 
75 
110 
75 
no 100 
150 
110 
150 
75 
no 75 
110 
65 
95 
65 
95 
90 
135 
90 
135 
70 
105 
70 
105 
110 
110 
100 
100 
75 
75 
90 
120 
90 
120 
100 
140 
115 
155 
90 
120 
105 
140 
110 
150 
85 
110 
heart 
rate 
(1/min) 
115 
125 
110 
128 
114 
125 
114 
130 
122 
162 
132 
152 
109 
129 
114 
128 
129 
153 
132 
156 
99 
112 
100 
118 
120 
123 
117 
122 
120 
118 
119 
113 
114 
112 
108 
125 
103 
119 
170 
185 
103 
126 
105 
124 
138 
159 
117 
129 
149 
154 
126 
vT 
(1) 
1 8 
1 8 
20 
23 
1 6 
20 
1 7 
20 
1 8 
28 
2 4 
31 
1 8 
2 2 
1 6 
2 2 
24 
2 5 
1 8 
2 4 
33 
3 3 
34 
34 
25 
2 8 
20 
26 
30 
27 
22 
2 1 
1 6 
20 
20 
2 1 
1 8 
1 8 
28 
28 
2 5 
26 
1 6 
1 6 
29 
40 
23 
25 
1 7 
1 8 
23 
respiratory 
rate 
(1/min) 
14 
21 
13 
13 
20 
20 
18 
21 
25 
25 
18 
22 
16 
19 
18 
18 
9 
11 
11 
12 
8 
9 
6 
8 
14 
14 
14 
14 
12 
12 
16 
18 
18 
14 
16 
20 
18 
21 
16 
22 
16 
22 
28 
35 
12 
11 
16 
17 
18 
20 
17 
V o : 
(1/min) 
1 25 
1 59 
1 20 
1 54 
1 21 
1 55 
1 16 
1 60 
1 55 
2 22 
1 65 
2 31 
1 16 
1 58 
1 18 
1 62 
0 97 
1 29 
0 99 
1 28 
1 43 
1 78 
1 42 
1 94 
1 16 
1 50 
1 26 
1 57 
1 59 
1 48 
1 57 
1 59 
1 07 
1 17 
1 39 
1 84 
1 33 
1 61 
1 81 
1 95 
1 62 
2 04 
1 34 
1 79 
1 19 
2 16 
1 71 
2 14 
1 26 
1 56 
1 54 
V C 0 3 
(1/min) 
1 21 
1 66 
1 14 
1 44 
1 12 
1 49 
1 10 
1 52 
1 44 
2 22 
1 65 
2 15 
1 08 
1 54 
1 09 
1 55 
0 85 
1 22 
0 93 
1 17 
1 19 
1 52 
1 15 
1 58 
1 10 
1 35 
1 09 
1 35 
1 37 
1 33 
1 45 
1 48 
1 09 
1 11 
1 31 
1 75 
1 28 
1 52 
1 62 
2 16 
1 51 
2 16 
1 27 
1 73 
1 40 
1.95 
1 51 
1 91 
1 16 
1.42 
1 43 
42 
P pUtC0 2 
(mm Hg) 
78 
82 
77 
81 
66 
73 
69 
74 
74 
78 
72 
75 
71 
79 
72 
81 
70 
77 
72 
78 
73 
80 
80 
87 
59 
68 
63 
69 
70 
72 
73 
73 
72 
73 
74 
82 
71 
77 
72 
77 
74 
78 
66 
68 
79 
84 
71 
79 
72 
76 
74 
P
vCO
: 
(mm Hg) 
71 
74 
69 
72 
61 
66 
63 
67 
67 
71 
66 
68 
65 
71 
66 
73 
64 
70 
66 
70 
67 
72 
72 
78 
55 
63 
59 
63 
64 
65 
67 
67 
65 
67 
67 
74 
65 
70 
66 
70 
68 
70 
61 
62 
71 
75 
65 
71 
66 
69 
67 
P
a C 0 2 
(mm Hg) 
49 
47 
47 
48 
39 
39 
38 
38 
35 
33 
40 
35 
38 
39 
41 
42 
46 
44 
44 
45 
48 
49 
53 
55 
32 
35 
39 
38 
38 
41 
42 
42 
40 
39 
44 
44 
42 
43 
37 
35 
41 
40 
32 
34 
43 
44 
42 
44 
41 
43 
41 
^pLitCOj 
С
аСО; 
(ml/100 ml) 
12 5 
14 7 
1 2 6 
1 3 7 
11.5 
13 6 
1 2 6 
1 4 5 
15 2 
17 1 
1 3 1 
1 5 7 
1 3 4 
1 5 8 
1 2 8 
1 5 7 
10 5 
13.7 
1 2 0 
13 6 
1 0 9 
1 3 0 
11 5 
13.8 
10 8 
13.2 
10 3 
1 2 6 
1 2 8 
1 2 8 
13.0 
13.1 
1 2 9 
13.8 
12 5 
15 5 
1 2 1 
14.1 
14 0 
16.1 
1 3 8 
15.1 
1 3 1 
1 3 4 
14 7 
15.8 
1 2 3 
14 4 
13.0 
13.5 
13.2 
C
v C 0 2 
C
a C 0 2 
(ml/100 ml) 
9 5 
11 5 
9 9 
10 5 
9 6 
11 4 
10 6 
12 3 
1 3 0 
11 6 
1 0 9 
13 5 
11 2 
13 1 
10 6 
12 8 
8 3 
10.9 
9 5 
1 0 8 
8 2 
9 9 
8 3 
9 9 
9 7 
11 4 
8 6 
10 7 
1 0 9 
10 6 
10 6 
10 7 
10 8 
Π 5 
10 0 
1 2 4 
9 9 
11 3 
11 9 
13 7 
11 3 
12 6 
11 5 
12 3 
11 9 
1 2 6 
10.0 
11 6 
1 0 6 
11 0 
11.0 
Qpbn 
(l/min) 
9 7 
11 3 
9 1 
10 6 
9 7 
10 9 
8 8 
1 0 5 
9 5 
13 0 
12 6 
1 3 7 
8 1 
9 7 
8 5 
9 9 
8 1 
8 9 
7 8 
8 6 
1 0 9 
11 7 
1 0 0 
11.5 
10 2 
10 2 
10 6 
1 0 7 
1 0 7 
10 4 
11 2 
11 3 
8 4 
8 0 
10 5 
11 3 
10 5 
1 0 8 
11 6 
13 4 
10 9 
1 4 3 
9 7 
1 2 9 
9 5 
12 3 
12 3 
1 3 2 
9.0 
1 0 5 
11 0 
Qv 
(l/mi 
1 2 7 
11 1 
11 6 
13 7 
11.7 
13 1 
1 0 4 
1 2 4 
11 1 
15 2 
15 2 
1 5 9 
9 6 
11 8 
10.3 
1 2 1 
10 2 
11 2 
9 8 
1 0 8 
14 5 
1 5 4 
1 3 9 
1 6 0 
11 3 
11 8 
1 2 7 
1 2 6 
1 2 6 
1 2 5 
1 3 7 
1 3 8 
10 1 
9 7 
13 1 
14 1 
12 9 
1 3 5 
13.7 
1 5 7 
13 4 
17 1 
11 1 
14 1 
11 8 
15 4 
15 1 
16 5 
10 9 
1 2 9 
1 2 9 
Qplat = 3 · 8 1 + 4 · 4 0 V o 2 S D Y X = 0 · 7 0 Γ = 0 · 8 9 
Q- = 4.87 + 5.25 V 0 2 8 ϋ γ Χ = 0 go r = Q 8 7 
in which Q and VQ are expressed in I/min. 
(17) 
(18) 
The validity of our results was judged by comparison with the data in the 
literature, in which use was made of the linear relation that exists during sub-
maximal exercise between the cardiac output and the oxygen consumption 
(Rowell 1969). For this use was made of published observations of invasively 
measured cardiac output values of young men during submaximal exercise in 
the sitting position on the bicycle ergometer. The required regression lines 
were obtained by calculating them from the data of Beveglrd et al. (1960) 
and Âstrand et al. (1964) and by borrowing them from the publication of 
Hermansen et al. (1970). These regression lines and the regression lines (17) 
and (18) of our observations are given in table 3.3. and in figure 3.1. Com-
pared with these data from the literature, the cardiac output (Qn^t), calcu-
lated via the Ppiatco, > turned out to be too low, while the cardiac output 
/ m m 20 
10 
- ¿ p i a l 
О* '/min 
2.5 
Figure 3.1. Relationship between cardiac output (Q) and oxygen consumption ( V 0 ) in 
young men during submaximal exercise sitting on the bicycle ergometer. Our results 
(Q
 b t and Q-) are compared with the regression lines of Bevegârd et al. (1960) (В), 
Âstrand et al. (1964) (Â) and Hermansen et al. (1970) (H). 
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Table 3.3. Relationship between cardiac output (Q) and oxygen consumption (V 0 ) in young men during submaximal exercise 
sitting on the bicycle ergometer. * 
Authors Method Regressjon Equation 
(Q and V 0 in 1/min) 
Number Number 
of of 
Obser- Subjects 
valions 
Bevegârd et al. 
1960 
Âstrand et al. 
1964 
Hermaneen et al. 
1970 
This study 
direct Fick for 0 2 Q = 4.65 + 5.75 V0 
indicator dilution Q = 4.64 + 5.21 V 0 
indicator dilution Q = 5.1 + 4.8 V0 
indirect Fick for C02 Qpjat = 
using the Pp]a tCo 3.81 + 4.40 V 0 
using the P ^ o Qv = 
4.87 + 5.25 V, 
SDy x = 0.85 r = 0.96 
SDy x = 1.44 г = 0.95 
S D y x = 1.8 
S D y x = 0.70 г = 0.89 
S D y x = 0.96 r = 0.87 
20 
40 
20 
50 
50 
10 
13 
13 
16 
16 
(Qy), calculated via the Pycc^ showed strikingly good agreement. The most 
valid calculation of the cardiac output (Qy) w a s thus obtained by using the 
PyCO s o that henceforth we will apply this method. 
3.3.2. The results of the investigation on the effects of pH and base excess 
During 11 experiments in 6 subjects the acid-base balance was examined in 
arterialized venous blood. The results are summarized in table 3.4. The 
cardiac output Q^ was calculated by applying the measured pH and base 
excess to the calculation programme for the CO2 dissociation, while the 
Qy was calculated via formula 15 with the established values for pH: 7.4 and 
for base excess: —2.5 maeq/1. 
The Qf values proved to be on the average about 3% higher than the Q^. 
During light and moderately heavy exercise with, as arbitrary measure, a 
heart rate < 150 beats/minute, the average pH was 7.38 ± 0.02 and the base 
excess —2.7 ± 1.3 maeq/1. During this exercise the average Q* was about 
2% higher than the Q^. During the heavier exercise (heart rate > 160 beats/ 
min) the average pH was 7.36 ± 0.01 and the base excess —4.3 ± 1.0 maeq/1. 
During this heavier exercise the average Q* was about 4% higher than the 
Qv-
18 0 V 1 ( l / m i n ) 
Figure 3.2. The relationship of cardiac output values determined by the CO2 rebreathing 
method during two consecutive exercise tests. Hatched lines are ± 10% from the line of 
identity. 
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3.3.3. The results of the investigation on the reproducibility 
The measurements during 18 exercise tests among 10 subjects were repeated 
after at least 5 days. The results of this are given in table 3.5. and also the 
calculated relative standard error of a single observation of these parameters. 
The relative SEX of the cardiac output values was about 4%. In figure 3.2. 
the % of the second investigation is set against that of the first investigation. 
The correlation data are: 
% 2 - 0.97 Qfi + 0.23 SDyx = 0.7 r = 0.92 (19) 
3.4. Discussion 
During submaximal exercise there is a linear relationship between cardiac 
output and oxygen consumption (Ekelund and Holmgren 1967, Rowell 
1969). This relationship is to some extent influenced by the age and sex of 
the subjects and by the kind of effort such as treadmill or bicycle exercise 
(Astrand et al. 1964, Becklake et al. 1965, Julius et al. 1967, Ekelund and 
Holmgren 1967, Stenberg et al. 1967), but above all by the body position 
(Beveglrd et al. 1960). At rest the cardiac output values are relatively lower 
so that a regression line without resting values has an equation different to 
that with resting values (Rowell 1969). Consequently, for the sake of accu-
Table 3.4. Effects of pH and base excess on the calculation of the cardiac output 
Subject 
2 
2 
11 
11 
12 
12 
14 
15 
15 
16 
16 
mean 
SD 
heart rate 
(beats/min) 
132 
152 
170 
185 
103 
126 
138 
117 
129 
149 
154 
141 
24 
Vo2 (1/min) 
1.65 
2.31 
1.84 
1.95 
1.62 
2.04 
1.49 
1.71 
2.14 
1.26 
1.56 
1.78 
0.31 
Qv 
(l/min) 
15.2 
15.9 
13.7 
15.7 
13.4 
17.1 
11.8 
15.1 
16.5 
10.9 
12.9 
14.4 
2.0 
pH 
7.37 
7.37 
7.36 
7.35 
7.37 
7.38 
7.37 
7.42 
7.40 
7.38 
7.36 
7.38 
0.02 
base excess 
(maeq/1) 
- 3 
—5 
- 3 
- 5 
- 3 
- 4 
- 4 
—1 
- 1 
- 3 
- 4 
- 3 
1 
Qv* 
(l/min) 
15.7 
16.3 
14.5 
16.4 
13.9 
17.4 
12.2 
15.1 
17.0 
11.2 
13.4 
14.8 
2.0 
Q* was calculated by substituting the measured values of pH and base excess in the cal-
culation programme of Godfrey (1970) for the CO3 dissociation curve. Q- was calculated 
by substituting assumed values for pH (7.4) and base excess (—2.5 maeq/1) in this calcula-
tion programme. 
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racy of the equation of our measuring results, only those regression lines were 
borrowed from the literature data that dealt with direct cardiac output deter­
minations made in young men only during submaximal exercise in a sitting 
position on the bicycle ergometer. The most valid determination of the 
cardiac output (Qy) was obtained by using the Русо2 > which had been calcu­
lated from the Ppiatco by correction for the alveolocapillary CO2 tension 
gradient (figure З.1., table 3.3.). Paterson and Cunningham (1976) came to 
the same conclusion. As in our investigation the Qy had proved to be the 
most valid, the reproducibility and the effect of the acid-base balance were 
investigated with reference to the Qy-
In our investigation the effect of the measured pH and base excess on the 
calculated cardiac output was limited (table 3.4.). The cardiac output (Qy) 
results, with assumed values for pH and base excess, were on the average 
about 3% lower than the cardiac output (Qf ) that was calculated with the 
aid of the measured pH and base excess. If we select from our experiments 
the light and moderately heavy exercises (heart rate less than 150/min), it 
turns out that the cardiac output (Qy) is underestimated by only about 2%. 
During heavier exercise this underestimation appears to be larger, which can 
be explained by the fall of the pH and further diminution of the base excess. 
Our measurements of pH and base excess during exercise were too limited to 
justify further corrections in the calculation programme of Godfrey (1970). 
The calculation of the C0 2 concentration gradient as applied in this investi­
gation was therefore found to be reasonably adequate, certainly during light 
and moderately heavy exercise. 
The reproducibility of the measurements was tested by repetition of the 
exercise test (table 3.5.). The heart rate during exercise was found to be 
satisfactorily reproducible with a relative standard error of a single observa­
tion (SEX) of 3%. This fact is well known (Sime et al. 1972), so that the 
heart rate is excellently suitable as a measure of the relative loading of the 
subject. The reproducibility of the measurings of the O2 consumption and 
CO2 production in this investigation was quite as good as that reported in 
the literature (Lukin 1963). The relative SEX of the Русо was about 3%, 
which seems to be greater than the coefficient of variation of 1.5% as pub­
lished by Godfrey and Wolf (1972). This difference may have been caused 
by the fact that Godfrey and Wolf calculated the coefficient of variation 
from repeated estimations during the same session. 
The reliability of this cardiac output measurement during exercise was good 
with a relative standard error of a single observation of about 4%. This value 
is of the same order of magnitude as the coefficient of variation of 5.7%, as 
published by Zeidifard et al. (1972), who also made measurements of the 
cardiac output according to the indirect Fick method for CO2 during repeated 
exercise tests. The reproducibility of these indirect measurements was found 
to be as good as that of invasive measurements during exercise (see table 3.6.). 
The latter techniques easily awaken emotions which may accompany haemo-
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Table 3 5 Reproducibility of respiratory and haemodynamic variables during exercise 
Subject Work load Period be V 0 V c o Pv c o P a C O 
tween the J ' ' ' 
(W) 2 exercise O/min) (1/min) (mm Hß) (mmHg) 
tests 1 2 1 2 1 2 1 2 
(days) 
1 
1 
2 
2 
2 
3 
3 
4 
4 
5 
5 
6 
6 
7 
8 
9 
10 
75 
110 
75 
110 
150 
75 
110 
65 
95 
90 
135 
70 
105 
110 
100 
75 
90 
120 
21 
21 
7 
7 
180 
7 
7 
5 
5 
7 
7 
11 
11 
5 
7 
11 
21 
21 
1 25 
1 59 
1 21 
1 55 
2 22 
1 16 
1 58 
0 97 
1 29 
1 43 
1 78 
1 16 
1 50 
1 54 
1 57 
1 07 
1 39 
1 84 
1 20 
1 54 
1 16 
160 
2 31 
1 18 
1 62 
0 99 
1 28 
1 42 
194 
1 26 
1 57 
1 48 
1 59 
1 17 
1 33 
161 
1 21 
1 66 
1 12 
1 49 
2 22 
1 08 
1 54 
0 85 
1 22 
1 19 
1 52 
1 10 
1 35 
1 37 
1 45 
1 09 
1 31 
1 75 
1 14 
1 44 
1 10 
1 52 
2 15 
1 09 
1 55 
0 93 
1 17 
1 15 
1 58 
1 09 
1 35 
1 33 
1 48 
1 11 
1 28 
1 52 
71 
74 
61 
66 
71 
65 
71 
64 
70 
67 
72 
55 
63 
64 
67 
65 
67 
74 
69 
72 
63 
67 
68 
66 
73 
66 
70 
72 
78 
59 
63 
65 
67 
67 
65 
70 
49 
47 
39 
39 
33 
38 
39 
46 
44 
48 
49 
32 
35 
38 
42 
40 
44 
44 
47 
48 
38 
37 
35 
41 
42 
44 
45 
53 
55 
39 
38 
41 
42 
39 
42 
43 
95 
11 5 
96 
11 4 
14 6 
11 2 
13 1 
83 
10 9 
82 
99 
97 
11 4 
10 9 
10 6 
108 
10 0 
12 4 
99 
10 5 
10 6 
12 3 
13 5 
10 6 
128 
95 
10 8 
8 3 
99 
86 
10 7 
10 6 
10 7 
11 8 
99 
11 3 
12 7 
14 4 
11 7 
13 1 
15 2 
96 
11 8 
10 2 
11 2 
14 5 
154 
11 3 
11 8 
12 6 
137 
10 1 
13 1 
14 1 
11 6 
13 7 
10 4 
12 4 
159 
10 3 
12 1 
98 
10 8 
13 9 
16 0 
12 7 
126 
12 5 
138 
97 
12 9 
13 5 
115 
125 
114 
125 
162 
109 
129 
129 
153 
99 
112 
120 
123 
120 
119 
114 
108 
125 
110 
128 
114 
130 
152 
114 
128 
132 
156 
100 
118 
117 
122 
118 
113 
112 
103 
119 
110 
115 
103 
105 
94 
88 
91 
79 
73 
146 
138 
94 
96 
105 
115 
89 
121 
113 
106 
107 
91 
95 
105 
90 
95 
74 
69 
139 
136 
109 
103 
106 
122 
87 
123 
113 
mean 2 0 ( 1 1 ) * 1 45 1 46 1 3 6 1 3 3 67 68 42 43 1 1 0 10 7 12 6 12 5 122 121 104 104 
SD 40 (6) 0 31 0 32 0 31 0 28 5 4 5 5 2 0 1 3 1 8 1 9 15 15 19 19 
relative SEX (%) 4 1 4 5 2 7 5 0 4 8 4 1 2 6 4 7 
* Without the third series of observations of subject 2 
Cv CO, ''aCO, 
(ml/100 ml) 
1 2 
Qv 
(1/min) 
1 2 
Heart rate 
(beats/mm) 
1 2 
Stroke 
volume (ml) 
1 2 
Table 3.6. The reproducibility of the cardiac output measured according different techni-
ques during submaximal exercise on different days. 
Authors 
Holmgren and Pernow 
1960 
Becklake et al. 1962 
Sannerstedt 1966 
Ekblometal . 1968 
Clausen et al. 1970 
Zeidifard et al. 1972 
This study 
Method 
direct Fick for 0 2 
foreign gas 
indicator dilution 
indicator dilution 
indicator dilution 
indirect Fick for CO, 
using the extrapola-
tion method 
indirect Fick for CO, 
using the plateau 
method 
indirect Fick for CO, 
using the plateau 
method 
Body position 
supine 
sitting 
sitting 
sitting 
sitting 
sitting 
sitting 
sitting 
Coefficient of variation 
or relative error of a 
single determination 
(SEX) 
5.2%* 
8.49% (SEX) 
7.3% (SEX) 
3.5% (SEX) 
6.1% 
8% 
5.7% 
4.1% (SEX ) 
* Repeated measurements during the same session. 
dynamic changes (Brod et al. 1976). On the contrary, the C02 rebreathing 
method is simple for test persons to carry out without any sensations of pain 
and therefore causes little stress, which is all to the good of the reproducibi-
lity of the haemodynamic variables. It was also found that there was no clear 
difference between the averages of heart rate and cardiac output in the first 
and second exercise tests (table 3.5.). 
3.5. Conclusions 
The determination of the cardiac output by the indirect principle of Fick for 
CO2 has been found to be valid and reliable during exercise. The cardiac 
output is evidently most accurately determined if the blood C02 concentra-
tions are approximated as well as possible. In the first place this implies that 
in the Fick formula the mixed venous CO2 tension must be used, this being 
obtained after correction of the C02 tension plateau for the alveolocapillary 
C02 gradient. Further, the C02 concentration in the blood must be approxi-
mated as well as possible, which can be done by applying a calculation pro-
gramme for the C02 dissociation curve (formula 15), in which the expected 
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changes in the acid-base balance during exercise are taken into account. 
This non-invasive determination of the cardiac output, as described in this 
chapter, will be employed for studying the haemodynamic effects of ß-
blockers during exercise. 
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CHAPTER 4 
Effects of propranolol and metoprolol on blood pressure 
and plasma renin activity in hypertensive patients 
4.1. Introduction 
The j3-blocker propranolol has proved to be an effective antihypertensive 
agent. Some workers have concluded that the antihypertensive action of 
propranolol is correlated to pretreatment plasma renin activity (PRA) and to 
the decrease of the PRA during medication (Bühler et al. 1972, Bühler et al. 
1973, Karlberg et al. 1976). Plasma aldosterone and urinary excretion of 
aldosterone were simultaneously reduced (Bühler et al. 1972, Drayer et al. 
1975b). It was accordingly suggested that the antihypertensive action of 
propranolol is due to suppression of renin release. Moreover, the pretreatment 
level of PRA was claimed to be of predictive value with regard to the hypo-
tensive action of propranolol. (Bühler et al. 1972, Bühler et al. 1975, Laragh 
1976). Other groups, however, have denied these relationships (Birkenhäger 
et al. 1971, Leonetti et al. 1975, Woods et al. 1975). 
The part of the study described in this chapter was carried out to compare 
the antihypertensive action of the subsequently developed β ι -selective 
blocker metoprolol with that of propranolol in hypertensive patients in 
relation to their effects on the renin-aldosterone system. The influence of the 
two substances on body weight and some laboratory variables, and the plasma 
concentrations of the j3-blockers were also registered. 
4.2. Patients and Methods 
4.2.1. Patients 
The study comprised eight men with untreated essential hypertension with­
out demonstrable cardiac or pulmonary disease. Some data for these patients 
are summarized in table 4.1. Essential hypertension was diagnosed by exami­
nation at the out-patient clinic. The blood pressure was assessed in the supine 
position after 15 minutes of bed rest. Plasma concentrations of minerals and 
creatinine, the presence of protein in urine, urinary sediment and the urinary 
excretion of vanillyl mandalic acid (VMA) were assessed. At these investiga­
tions no abnormalities were found. Plasma renin activity (PRA
chi) was deter­
mined at noon after 5 days of medication with chlorthalidone (100 mg once 
daily) and 3 hours of ambulation according to the method of Drayer et al. 
(1975a). In the two patients who had an elevated PRA
ch], intravenous 
pyelography was added to the investigations. There were no indications of a 
renal cause. 
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Table 4.1. Some data concerning the θ male hypertensive patients 
Patient 
(no) 
1 
2 
3 
4 
5 
6 
7 
8 
Age 
(yr) 
33 
28 
33 
4 4 
47 
26 
39 
21 
Height 
(m) 
1.80 
1.77 
1.72 
1.64 
1.82 
1.80 
1.72 
1.77 
Weight 
(kg) 
92.2 
81.4 
64.3 
61.5 
88.6 
68.5 
77.6 
75.6 
Blood pressure4" 
(mm Hg) 
150/110 
150/108 
160/110 
170/112 
150/100 
168/102 
162/108 
158/104 
PRA^* 
(ng/10 ml 3h) 
1450 
9 6 3 
563 
700 
4 0 3 
1525 
584 
9 2 5 
serum 
creatinine 
(μπιοΐ/ΐ) 
102 
71 
88 
77 
95 
62 
98 
84 
+
 Blood pressure measured after 15 minutes rest in the supine position. 
* PRA^j measured after 5 days of medication with chlorthalidone and 3 hours of ambu-
lation(normal values 275 — 1100 ng/10 ml 3h) 
The patients consented to participation in this study after being informed of 
its purpose, the nature of the procedures and the possible adverse reactions. 
4.2.2. Design of the study 
Propranolol (80 mg thrice daily) and metoprolol (100 mg thrice daily) were 
compared with each other and with placebo in a double blind cross-over 
study (figure 4.1.)· Tablets of identical appearance were used. There were 
T I M E l w . k s ) 0 « » 12 1β 
PROPRANOLOL PLACEBO METOPROLOL 
., t « « 
PLACEBO 
METOPROLOL PLACEBO PROPRANOLOL 
• i l 
C L I N I C A L V I S I T * * * * * * * * * 
ADRENALINE * * * * * 
I N F U S I O N 
EXERCISE TEST * * * * * 
Figure 4.1. The design of the study 
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four consecutive periods of medication, each lasting four weeks: placebo, 
β — blocker,placebo, ß-blocker. The effective agents were given in randomized 
order. Every 2 weeks the patients attended the clinic for control of blood 
pressure, heart rate, intake of drugs and adverse reactions. At the end of each 
four-week period an infusion of adrenaline was given and an exercise test 
was performed. After this cross-over study 7 patients continued treatment 
with a j3-blocker in the same dose: 5 patients preferred metoprolol and 2 
propranolol. After 6 months of treatment this set of investigations was 
repeated. 
4.2.3. Methods 
The investigations were carried out in a room with a constant temperature 
(190C), starting at 09.00 a.m., 2 hours after ingestion of the morning dose. 
The patients were asked to take a light breakfast without coffee, and to 
abstain from smoking. To begin with, blood pressure and heart rate were 
measured in the supine and upright position after 15 minutes' bed rest. The 
blood pressure was determined by auscultation with a mercury manometer. 
The diastolic value was taken as the start of Korotkoff sounds phase IV. 
After that blood samples were taken for determination of plasma minerals, 
serum creatinine, glucose, haemoglobin and haematocrit. 
The concentrations of propranolol and metoprolol in plasma were determined 
by gas chromatography according to the methods of di Salle et al. 1973 and 
Ervik 1975, respectively, in samples which had been stored at —20°C until 
analysis*. 
Next, the haemodynamic effects of an infusion of adrenaline were investi-
gated (chapter 5). After a further good half-hour of bed rest, haemodynamic 
and respiratory variables were measured during exercise (chapter 6). After 
this submaximal exercise, lasting 15 minutes, a blood sample was taken for 
determination of PRA and plasma aldosterone by radioimmunoassay. 
At every clinical visit the patients were questioned about adverse reactions. 
Drug intake was checked by counting the remaining tablets after each period. 
The percentage ingestion appeared to be over 90% on all occasions. 
4.2.4. Statistics 
All results are presented as mean ± SEM. As the values appeared to be nor-
mally distributed, statistical analysis was carried out using Student's t-test 
for paired observations. The effects of the two β -blockers were compared 
* These determinations were performed at the analytical laboratory of AB Hässle, Möln-
dal, Sweden. 
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Table 4.2. Blood pressure and heart rate at rest after 4 weeks on placebo and after 4 weeks of (3-blockade (mean ± SEM, η = 8) 
Systolic pressure (mm Hg) 
supine 
erect 
Diastolic pressure (mm Hg) 
supine 
erect 
Heart rate (beats/min) 
supine 
erect 
Placebo 
151 ± 4 
1 5 9 + 5 
105 ± 2 
107 ± 3 
81 ± 5 
88 ± 5 
Propranolol 
1 4 2 ± 6 
137 ± 4 
9 2 ± 3 
9 2 ± 4 
6 1 + 2 
66 ± 3 
P* 
0.05 
< 0.001 
< 0.001 
< 0.005 
< 0.001 
< 0.001 
Placebo 
154 ± 5 
1 6 5 + 6 
1 0 3 ± 2 
1 0 6 ± 3 
77 ± 3 
80 ± 3 
Metoprolol 
140 ± 4 
144 ± 5 
92 ± 3 
9 8 + 3 
59 ± 3 
60 ± 3 
P** 
< 0.01 
< 0.01 
< 0.01 
< 0.01 
< 0.001 
< 0.001 
P*** 
NS 
N S 
NS 
NS 
NS 
NS 
* : propranolol versus placebo 
** : metoprolol versus placebo 
* * * : propranolol versus metoprolol 
NS : p > 0 . 1 0 
with each other and with the values obtained during the placebo period 
preceding treatment with the /3-blocker in question. Correlations were calcu­
lated according to Pearson's technique. 
4.3. Results 
4.3.1. Results of the cross-over study, propranolol versus metoprolol 
No significant differences were found between the values recorded in the 
two placebo periods. 
Propranolol and metoprolol gave an approximately equal reduction in blood 
pressure and heart rate (table 4.2., figure 4.2.). 
Body weights and laboratory findings are given in table 4.3. After 4 weeks of 
treatment, propranolol gave a fall in PR.A, whereas metoprolol had no signifi­
cant influence on this variable. The plasma levels of the |3-blockers were 
within the expected ranges. The other laboratory variables, including plasma 
aldosterone, and body weight were not influenced by 0-blockade. 
No significant correlations were found between plasma propranolol levels 
and the changes of blood pressure, heart rate and PRA. The percentage 
decrease of the diastolic pressure was significantly correlated to the logarithm 
of the plasma metoprolol level (r = 0.80, ρ < 0.02). No significant relation­
ships were found between the metoprolol levels and the changes of systolic 
pressure, heart rate or PRA (table 4.4.). 
PRA values measured after exercise during administration of placebo were 
significantly correlated to the PRA^j levels after stimulation with chlor­
thalidone (r = 0.81, ρ < 0.02). The antihypertensive actions of propranolol 
and metoprolol were not correlated to Р Е А
С І 1 І nor to PRA in the placebo 
periods. Nor was a significant relationship found between the decrease of 
PRA and antihypertensive action of propranolol and metoprolol (table 4.4.). 
Table 4.4. Correlation coefficients"1" between the percentage decrease of blood pressure during 
ß-blockade and some PRA values 
Propranolol Metoprolol 
Δ systolic pressure Δ diastolic pressure Δ systolic pressure Δ diastolic pressure 
— 0.46 —0.25 0.13 —0.40 
— 0.49 —0.36 0.30 —0.13 
— 0.13 0.21 —0.06 —0.67 
+
 ρ > 0.10 for all correlations 
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Figure 4.2. Changes of blood pressure and heart rate during treatment with propranolol 
and metoprolol compared to placebo values. 
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Table 4.3. Body weight and laboratory values after 4 weeks on placebo and after 4 weeks of 0-blockade. (mean ± SEM, η = 8) 
Body weight (kg) 
Plasma electrolytes 
(mmol/1) 
sodium 
potassium 
chloride 
Serum creatinine 
(μ mol ) 
Serum uric acid 
(mmol/1) 
Haemoglobin 
(mmol/1) 
Haematocrit (1/1) 
Glucose (mmol/1) 
Plasma renin activity 
( n g / 1 0 m l 3 h ) 
Plasma aldosterone 
(ng/100 ml) 
Plasma level 
(J-blocker (ng/ml) 
(Range) 
Placebo 
76.2 ± 4.3 
139 ± 1 
3.6 ± 0.1 
1 0 2 ± 1 
86 ± 5 
0.35 ± 0.02 
10.4 ± 0.2 
0.49 ± 0.01 
5.4± 0.4 
1 0 8 + 11 
17 + 2 
Propranolol 
76.6 ± 4.1 
139 ± 1 
3.8 ± 0.1 
104 ± 1 
8 3 ± 7 
0.32 ± 0.02 
10.1 ± 0.2 
0.48 ± 0.01 
5.9 ± 0.4 
66 ± 8 
18 ± 3 
134 ± 27 
( 3 4 - 2 7 0 ) 
P* 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
< 0,01 
NS 
Placebo 
77.2 ± 
140 + 
3.7 + 
103 + 
8 3 + 
0.35 ± 
10.1 + 
0.48 + 
5.8 ± 
97 Í 
14 ± 
4.0 
1 
0.1 
1 
4 
0.02 
0.3 
0.01 
0.8 
10 
2 
Metoprolol 
77.1 ± 4.1 
139 ± 1 
3.8 ± 0.2 
1 0 1 + 1 
83 ± 4 
0.35 ± 0.02 
9.9 ± 0.2 
0.47 ± 0.01 
5.5 ± 0.3 
8 4 + 9 
18 ± 5 
1 7 0 ± 17 
( 9 8 - 2 3 6 ) 
P** 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
P*** 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
0.05 < ρ < 
NS 
0.1 
p * * metoprolol versus placebo 
en p * * * metoprolol versus propranolol 
<D NS : ρ > 0.1 
Ci 
о 
Table 4.5. Changes of blood pressure, heart rate and PRA after 4 weeks and 6 months of p-blockade in comparison with 
placebo values. 
Metoprolol 
patient 3 
4 
5 
6 
7 
mean 
SEM 
Propranolol 
patient 1 
β 
Δ systolic/diastolic 
pressure 
(mm Hg) 
4 weeks 
- 1 0 / - 1 6 
+2/0 
- 1 2 / - 1 0 
- 1 6 / - 8 
- 3 2 / - 2 0 
- 1 4 / - 1 1 
5/3 
- 6 / - 1 4 
- 3 2 / - 2 4 
6 months 
- 1 0 / - 2 
+6/-4 
- 2 0 / - 1 2 
- 4 / - 6 
-21-4 
-61-6 
4/2 
NS 
+ 1/-16 
+6/-6 
Δ heart rate 
(beats/min) 
4 weeks 
- 1 8 
- 2 0 
- 2 4 
- 2 8 
- 1 8 
- 2 2 
2 
NS 
- 2 4 
- 2 7 
6 months 
- 1 8 
- 2 2 
- 1 4 
- 1 2 
- 1 2 
- 1 6 
2 
- 2 4 
- 1 8 
ΔΡ.Κ.Α. 
(ng/10 ml 3 hr) 
4 weeks 
- 9 
- 5 9 
0 
- 5 3 
- 8 
- 2 6 
12 
6 months 
- 8 0 
- 7 5 
- 4 9 
- 8 5 
- 5 1 
- 6 8 
8 
p < 0.05 
- 5 0 
- 4 0 
- 1 0 4 
- 8 9 
plasma level β -blocker 
(ng/ml) 
4 weeks 
2 3 6 
9 8 
196 
152 
168 
170 
23 
NS 
34 
270 
6 months 
308 
55 
110 
78 
201 
150 
47 
105 
191 
The adverse reactions were of little importance and had no therapeutic con-
sequences. During propranolol treatment two patients reported shortness of 
breath. One of these patients complained of the same symptom during the 
metoprolol period. During propranolol medication one patient reported 
increased bowel motions up to three times a day. None of these patients 
complained of fatigue, muscle weakness or coldness of the extremities. 
4.3.2. Results after 6 months of ß-blockade 
Changes in the most important variables compared to placebo values after 
6 months of j3-blockade are presented in table 4.5. In this table changes of 
blood pressure and heart rate measured with the patients in the supine posi-
tion are given. The values measured with the patients in the erect position 
showed analogous changes. The effect of both β -blockers on blood pressure 
and heart rate remained largely unchanged after 6 months of treatment. 
Plasma renin activity after 6 months of metoprolol treatment had decreased 
markedly compared to placebo values (p < 0.01) and also compared to obser­
vations after 4 weeks of metoprolol treatment (p < 0.05). PRA had also 
decreased further after 6 months of treatment in the two patients who con­
tinued propranolol treatment. No change was observed in the other labora­
tory values, including plasma aldosterone, after 6 months. Nor was there any 
change in body weight. 
None of these 7 patients reported any side effect after 6 months of ^-blockade. 
4.4. Discussion 
The two )3-blockers in the doses used gave the same reduction in resting heart 
rate, which is in agreement with previous findings (Johnsson et al. 1975b, 
Bengtsson 1976b). A clear difference in haemodynamic effects has been 
established between acute and long-term jS-blockade. Heart rate and cardiac 
output decrease to the same extent after acute intravenous and during long-
term oral medication with propranolol, whereas the antihypertensive effect 
occurs only during long-term treatment (Tarazi and Dustan 1972, Hansson 
et al. 1974). Acute ß-blockade has no marked influence on blood pressure, 
owing to an increase in peripheral resistance. The latter effect has disappeared 
after 4 weeks of treatment (Hansson et al. 1974). In this study, therefore, 
both j3-blocking agents were administered during a four-week period, which 
has been found to be long enough to judge the antihypertensive effect 
(Zacharias and Cowen 1970, Hansson et al. 1974, Bengtsson 1976a). Our 
results are in agreement with the finding in previous studies that propranolol 
and metoprolol gave an equal reduction of blood pressure. (Bengtsson 1976b, 
Davidson et al. 1976). 
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Plasma renin activity was measured in our patients after stimulation with 
chlorthalidone (PRA,,^) as part of the hypertension work-up at the out-
patient clinic. During this study PRA was also determined after 15 minutes 
submaximal exercise which stimulates renin release in a more physiologicol 
way (Kotchen et al. 1971). PRAchi was much higher than the PRA after 
exercise during placebo administration, but the two variables appeared to be 
significantly correlated. 
Propranolol reduced PRA after 4 weeks of treatment, whereas metoprolol 
had no significant effect on PRA. After 6 months of treatment with meto-
prolol, however, PRA was significantly reduced. Metoprolol can apparently 
suppress renin release, which is in agreement with other studies (Bühler et 
al. 1975, Attman et al. 1975, Hansson 1976). This suggests that renin release 
can be stimulated partly via β ι -receptors in the kidney. So far, however, 
the discrepancy between the effects of metoprolol, and possibly of pro­
pranolol, on PRA after 4 weeks and after 6 months of treatment has not 
been satisfactorily explained. 
On the basis of their findings, Bühler and Laragh suggest that the antihyper-
tensive effect of propranolol is due to an inhibitory action on renin release 
and that pretreatment PRA levels are of predictive value for the therapeutic 
response (Bühler et al. 1972, Bühler et al. 1973, Laragh 1976). Other studies, 
however, have not shown a relationship between the initial PRA and the anti-
hypertensive action of propranolol, or between the fall in PRA and the 
decrease in blood pressure. (Birkenhäger et al. 1971, Hansson et al. 1974, 
Leonetti et al. 1975, Woods et al. 1976, Birkenhäger et al. 1977). Other 
j3-blocking drugs have been found to produce different effects on PRA, 
without any relationship with their antihypertensive action (Stokes et al. 
1974, Amery et al. 1974, Stokes et al. 1976). Moreover, a greater fall in 
blood pressure occurred, without a decrease in PRA, when a diuretic was 
used in combination with propranolol or another ß-blocking agent in the 
treatment of hypertension (Bravo et al. 1975, Woods et al. 1976, Hollifield 
et al. 1976, Chalmers et al. 1976). All these data suggest that pretreatment 
PRA levels are of little value as a guidance for the choice of a therapeutic agent 
(Woods et al. 1976, Festen 1977) and that the antihypertensive action of 
β -blockers is not mainly due to suppression of PRA. This last view is sup­
ported by the fact that, in the present study, propranolol and metoprolol 
gave an equal reduction of blood pressure, whilst there was no question of an 
equal effect on PRA. Moreover, PRA appeared to have decreased more 
after 6 months of treatment without any further reduction of blood pressure. 
Plasma aldosterone never changed during treatment with either (3-blocking 
drug, in spite of the decrease of PRA. Since aldosterone secretion also depends 
on other stimuli, only a slight decrease in urinary aldosterone excretion was 
found in combination with the reduction in PRA due to propranolol (Bühler 
et al. 1972). Hence, it is not surprising that changes in plasma aldosterone 
levels were not found in this study. 
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A wide range of plasma concentrations has been found after ingestion of 
propranolol and metoprolol tablets (Hansson et al. 1974, Bengtsson et al. 
1975); this variable was also assessed in this study. We found a significant 
correlation between the logarithm of the plasma metoprolol level and the 
percentage decrease of the diastolic pressure. Bengtsson et al. (1975) investi­
gated the relationships between plasma metoprolol levels and the effects on 
blood pressure and heart rate during treatment of hypertension. They found 
a significant correlation only between metoprolol levels and the decrease 
of heart rate. This relationship could not be confirmed in this study. 
No significant correlations were found between the variables measured and 
plasma propranolol levels. Nor did Hansson et al. (1974) find any correlation 
between plasma propranolol concentrations and the decrease in blood pres­
sure or heart rate in hypertensive patients during treatment with propranolol 
in a dosage comparable to ours. 
Both propranolol and metoprolol were well tolerated. Very few side effects 
were reported. Body weight and other laboratory values did not appear to 
change. Notably, no changes in serum levels of uric acid or creatinine were 
observed. In this respect Bengtsson (1976b) reported similar findings in a 
comparative study of propranolol and metoprolol. Drayer et al. (1975b), 
however, found a significant increase of body weight and serum creatinine 
during antihypertensive treatment with propranolol in a higher dose. 
4.5. Summary 
A double blind cross-over comparison between the non-selective ^-blocker 
propranolol and the β --selective blocker metoprolol was carried out in eight 
hypertensive patients. At the end of each four-week period of medication 
blood pressure and heart rate were measured and some laboratory variables 
were investigated, including plasma renin activity (PRA) and plasma aldo­
sterone. Propranolol and metoprolol gave approximately the same reduction 
of blood pressure and heart rate. Propranolol caused a decrease of PRA, 
whereas metoprolol had no significant effect on PRA. Neither of the two 
β -blockers influenced body weight or other laboratory values, including 
plasma aldosterone. The decrease of the diastolic pressure during metoprolol 
medication was significantly correlated to the plasma level of the drug. 
In 5 patients who continued metoprolol treatment, PRA was suppressed 
after 6 months. 
The observations that the two β -blocking agents reduced blood pressure 
equally without having an equal effect on PRA suggests that the antihyper­
tensive action of j3-blockers is mainly due to other mechanisms than sup­
pression of PRA. 
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CHAPTER 5 
Haemodynamic effects of adrenaline during treatment of 
hypertensive patients with propranolol and metoprolol* 
5.1. Introduction 
In the past ten years the /3-blocker propranolol has proved to be an effective 
antihypertensive agent (Gillam and Prichard 1976). The ßl -selective blockers 
subsequently developed, such as practolol and metoprolol, reduce blood 
pressure and pulse rate to the same degree as propranolol (Bengtsson 1976b, 
Davidson et al. 1976). From a theoretical point of view in hypertension a 
selective ßl -adrenoceptor blocker might be preferred to a non-selective 
blocker, due to its much less pronounced effect on vascular ß2 -receptors. 
This problem has been elucidated in normal subjects premedicated with pro-
pranolol or metoprolol (Johnsson 1975); during an adrenaline infusion a 
marked increase in diastolic blood pressure and in forearm vascular resistance 
was recorded in the studies with propranolol, whereas the vasodilator effect 
of adrenaline remained largely intact in the metoprolol studies. 
However, Johnsson studied the effect of adrenaline after a single intravenous 
dose of ß-blockers in healthy subjects and the effect of a single dose cannot 
be equated a priori with the effect of steady state medication in hypertensive 
patients. It is an established fact, for example, that peripheral resistance 
increases after administration of a single dose of propranolol. A hypotensive 
effect develops gradually, however, which is associated with an unchanged 
or a gradually decreased peripheral resistance (Hansson et al. 1974, Tarazi 
and Dustan 1972). Therefore, we have studied the interaction between adre-
naline and the j3-blockers propranolol and metoprolol in hypertensive patients 
who had taken these agents in therapeutic doses for some considerable time. 
5.2. Patients and methods 
5.2.1. Patients 
The study comprised eight men with untreated essential hypertension, 
without demonstrable cardiac complications. These patients are described 
in detail in chapter 4. 
* A part of this chapter has been published in The British Medical Journal and in The 
European Journal of Clinical Pharmacology (van Herwaarden et al. 1977). 
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5.2.2. Design of the study 
Propranolol (80 mg thrice daily) and metoprolol (100 mg thrice daily) were 
compared with each other and with a placebo in a double blind cross-over 
study, which is described in detail in the preceding chapter. There were four 
consecutive periods of medication, each lasting four weeks: placebo, ß-blocker, 
placebo, ^-blocker. At the end of each four-week period the same set of in-
vestigations was performed. After this cross-over study 7 patients continued 
treatment with a ß-blocker in the same dose, 5 preferred metoprolol and 
2 propranolol. After 6 months of treatment these investigations were repeated. 
The investigations were carried out in a room with a constant temperature of 
19°C, two hours after ingestion of the morning dose. To begin with, blood-
pressure and heart rate were measured at rest. Further blood samples were 
taken for chemical analysis, such as plasma level of the β -blocker. The results 
of this part of the study are presented in chapter 4. Next, the effects of an 
adrenaline infusion on blood pressure, heart rate and blood flow in the fore­
arm were measured. 
5.2.3. Adrenaline infusion test 
The effect of the adrenaline infusion was studied in the supine patient. 
The schedule of the adrenaline infusion test is presented in figure 5.1. After 
30 minutes' rest, adrenaline was infused via a vein in the left arm. The dose 
was successively increased within 6 minutes up to 8 ßg/min; this dosage was 
maintained for 6 minutes. 
T I M E (mi nutes ) 
A D R E N A L I NE i.v. 
(/jg/min) 
-30 -8 
I /A - 1 I г^  
0 4 
—ι 1 r-
12 16 
β ι-
Ο L-
B I O O D PRESSURE 
A N D HEART RATE * * * * * * * * * * * * * 
B L O O D F L O W FOREARM
 + 
Figure 5.1. Schedule of the adrenaline infusion test. 
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The blood flow was measured in the right forearm with a mercury strain-
gauge Plethysmograph (Brakkee and Vendrik 1966) during venous occlusion 
achieved by inflation of a sphygmomanometer cuff on the upper arm to 50 
mm Hg. For this purpose the right arm was elevated obliquely in an arm 
support. The blood flow was measured before, during and 4 minutes after 
adrenaline administration. Throughout the entire procedure, the electro-
cardiogram was recorded every 2 minutes and at the same time the blood 
pressure in the right arm was measured by auscultation. For blood pressure 
and heart rate during adrenaline the means of the measurements after 8 and 
10 minutes of infusion were used. 
The mean arterial pressure (MAP) was calculated by adding one-third of the 
pulse pressure to the diastolic pressure. The vascular resistance in the forearm, 
expressed in arbitrary units, was calculated by dividing the MAP by the blood 
flow in the forearm. 
5.2.4. Statistics 
All results are presented as mean ± SEM. As the values appeared to be nor-
mally distributed, statistical analysis was carried out with Student's t-test for 
paired observations. The effects of the two /3-blockers were compared with 
each other and with the values obtained during the placebo period preceding 
treatment with the jS-blocker in question. Correlations were calculated 
according to Pearson. 
5.3. Results 
5.3.2. Results of the cross-over study, propranolol versus metoprolol 
The effects of the adrenaline infusion are presented in tables 5.1 and 5.2. It 
should be noted that the blood pressures listed were about 10 mm Hg lower 
than those obtained by conventional sphygmomanometry, because in the 
procedure outlined the blood pressure was measured in the elevated right 
arm. The changes in relation to the initial values are represented graphically 
in figures 5.2 and 5.3. These latter illustrate the results of only one placebo 
period: the one preceding the propranolol period. No significant difference 
was found between values recorded in the two placebo periods. 
Blood pressure and heart rate immediately prior to the adrenaline infusion 
were also lower during the propranolol and metoprolol period than during 
the preceding placebo periods. Pulse pressure, blood flow and vascular resis-
tance in the forearm were at this time not significantly different in the 
various periods (tables 5.1 and 5.2). 
During the placebo period, adrenaline caused an increase in heart rate and 
systolic pressure, and a decrease in diastolic pressure. The pulse pressure 
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Table 5.1. Haemodynamic variabeles measured before and during adrenaline infusion after 4 weeks on placebo and after 
4 weeks of treatment with propranolol (mean ± SEM, η - 8) 
Placebo Propranolol Ρ values propranolol 
versus placebo 
before during 
adrenaline adrenaline ρ 
before during 
adrenaline adrenaline ρ 
before during 
adrenaline adrenaline 
systolic pressure 
(mmHg) 
mean arterial 
pressure (mm Hg) 
diastolic pressure 
(mm Hg) 
pulse pressure 
(mm Hg) 
heart rate 
(beats/min) 
blood flow 
(ml/100 ml tissue 
min) 
vascular resistance 
(units) 
141 ± 3 158 ± 4 < 0.005 129 ± 4 154 ± 5 < 0.005 < 0.02 
105 ± 2 105 ± 2 
74 ± 4 
NS 
53 ± 4 81 ± 6 < 0.001 51 ± 4 57 >• 5 NS NS 
2.7 t 0.3 5.2 ± 0.6 < 0.001 2.9 > 0.4 2.2 * 0.2 NS NS 
45 ± 7 23 ± 4 < 0.001 37 ± 4 5 8 + 6 < 0.02 NS 
NS* 
96 ± 2 117 + 3 < 0.001 < 0.001 < 0.01 
89 ± 2 78 ± 3 < 0.01 79 ± 2 98 ± 3 < 0.001 < 0.01 < 0.005 
< 0.02 
90 · 5 < 0.001 56 ± 3 46 ± 4 < 0.005 < 0.001 < 0.001 
< 0.005 
< 0.005 
* not significant: ρ > 0.10 
Table 5.2. Haemodynamic variabeles measured before and during adrenaline infusion after 4 weeks on placebo and after 
4 weeks of treatment with metoprolol (mean ± SEM, η = 8) 
Placebo Metoprolol 
Ρ values metoprolol 
versus placebo 
before during 
adrenaline adrenaline ρ 
before during 
adrenaline adrenaline ρ 
before during 
adrenaline adrenaline 
systolic pressure 
(mm Hg) 
mean arterial 
pressure (mm Hg) 
diastolic pressure 
(mm Hg) 
pulse pressure 
(mm Hg) 
heart rate 
(beats/min) 
bloodflow 
(ml/100 ml tissue. 
min) 
106 ± 2 105 ± 2 
89 ± 2 8 1 + 3 
52 ± 2 
72 ± 4 
vascular resistance 36 ι 4 
(units) 
81 ± 5 
86 ± 5 
< 0.001 
NS 
< 0.05 
< 0.001 
< 0.001 
134 ± 2 
99 ± 2 
81 ± 3 
53 ± 4 
55 ± 3 
142 ± 3 
104 ± 2 
84 ± 2 
58 ± 4 
56 ± 3 
0.05< 
NS 
NS 
NS 
NS 
:p<o.i < 0.05 
< 0.01 
< 0.01 
NS 
< 0.001 
< 0.01 
N S * 
NS 
< 0.01 
< 0.00 
3.2 ± 0.3 5.2 ± 0.7 < 0.05 3.2 ± 0.4 3.9 ± 0.4 < 0.05 NS 
2 3 + 3 < 0.01 3 3 + 4 2 8 + 3 0.05<p<0.1 NS 
0.05<p<0.1 
< 0.05 
* not significant: ρ > 0.10 
<7> 
increased, but the MAP remained unchanged (figure 5.2). The blood flow in 
the forearm showed a significant increase during adrenaline infusion and the 
calculated vascular resistance in the forearm decreased (figure 5.3). 
Adrenaline in combination with propranolol caused a marked increase both 
of the systolic and the diastolic pressure (figure 5.2; table 5.1). The pulse 
pressure remained unchanged and the heart rate decreased. Instead of an 
increase in forearm blood flow as in the placebo period, the blood flow 
tended to decrease. The calculated vascular resistance in the forearm increased 
after adrenaline infusion during propranolol treatment. 
During metoprolol medication, adrenaline caused only a slight increase in 
systolic pressure. It had no demonstrable effect on diastolic pressure and 
MAP, nor on pulse pressure and heart rate (figure 5.2, table 5.2) The increase 
if c££ 
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Fig. 5 2. Changes in blood pressure and heart rate induced by the intravenous infusion of 
adrenaline after 4 weeks of treatment with propranolol, metoprolol or a placebo in 8 
hypertensive patients. 
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Fig. 5.3. Changes in bloodflow and vascular resistance m the forearm, induced by the 
intravenous infusion of adrenaline after 4 weeks of treatment with propranolol, metoprolol 
or a placebo in 8 hypertensive patients. 
in blood flow in the forearm, produced by adrenaline during the placebo 
period partly persisted during metoprolol medication. The peripheral vascular 
resistance in the forearm decreased (figure 5.3). 
During all periods, the effect of adrenaline had disappeared within 4 minutes 
of discontinuation of the infusion. 
The haemodynamic changes which occurred during interaction of adrenaline 
with propranolol and with metoprolol showed significant differences. Prior 
to infusion of adrenaline, the haemodynamic parameters measured during 
the propranolol period did not differ significantly from those found during 
the metoprolol period. During the interaction of adrenaline with metoprolol, 
the systolic and diastolic pressures and the MAP were lower than during the 
interaction with propranolol (0.05 < ρ < 0.1; ρ < 0.01; ρ < 0.01). The 
bradycardia which adrenaline caused during propranolol medication, did not 
occur during treatment with metoprolol (p< 0.05). On infusion of adrenaline, 
the blood flow in the forearm was higher (p < 0.01) and the vascular resis­
tance lower (p < 0.01) during metoprolol than during propranolol medication. 
No significant correlations were found between plasma levels of both β-
blockers and the haemodynamic effects of adrenaline. 
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Three patients complained of a pressing sensation on the chest and one pa­
tient of an unpleasant feeling in the stomach after the start of the adrenaline 
infusion during propranolol treatment. These sensations disappeared immedi­
ately after stopping the adrenaline infusion. No such complaints were 
expressed during any of the other adrenaline infusion tests. 
No pathological ECG changes were recorded during any of these experiments. 
5.3.2. Results after 6 months of β-blockade 
Adrenaline caused haemodynamic changes after 6 months of j3-blockade, 
similar to those measured after 4 weeks of treatment (table 5.3). 
Table 5.3. Haemodynamic changes during adrenaline infusion after 6 months of/3-blockade 
Metoprolol 
Propranolol 
* p < 0.05 
pat ient 
n o 
3 
4 
5 
6 
7 
mean ± 
1 
8 
mean 
5.4. Discussion 
SEM 
Δ hear t rate 
(beats/min) 
- 8 
0 
+10 
0 
+ 7 
+ 2 ± 3 
—20 
- 1 4 
- 1 7 
Δ M.A.P. 
( m m Hg) 
— 2 
- 5 
+ 16 
+ 7 
+ 4 
+ 6 ± 
+22 
+29 
+26 
4 
Δ bloodflow 
(ml/100 ml min) 
+ 1.3 
+ 1.7 
+4.0 
+0.7 
+3.1 
+2.2 ± 
—0.8 
- 0 . 8 
- 0 . 8 
0.6* 
Δ vase, resist. 
(units) 
- 1 9 
- 4 6 
- 2 3 
- 1 3 
- 4 3 
- 2 9 ± 7 * 
+70 
+44 
+57 
During the placebo periods, adrenaline infusion caused an increase in heart 
rate, systolic pressure, pulse pressure and blood flow in the forearm, and a 
decrease in diastolic blood pressure and vascular resistance in the forearm. 
The mean arterial pressure remained unchanged. These haemodynamic 
changes are produced by adrenergic stimulation of a- and of ßi - and ßj-
receptors. Adrenaline is known to have more affinity for 02- than iorß\-
receptors (Carlsson et al. 1972). According to Lands et al. (1967), the 02-
receptors in the cardiovascular system are localized in the muscular arterioles, 
and the 0, -receptors in the heart. It was found later, however, that the heart 
contains 02 -receptors as well (Carlsson et al. 1972). The decrease in diastolic 
pressure and vascular resistance in the forearm which occurred during adrena-
line infusion probably resulted from vasodilatation in muscle tissue caused 
by stimulation of 02 -receptors. It seems likely that other changes such as the 
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increase in systolic pressure, pulse pressure and heart rate, were partly caused 
by stimulation of cardiac β -receptors. Moreover, it is possible that adrenaline 
not only directly stimulated the cardiac receptors, but also did so indirectly 
via the baroreceptor reflex, in response to the vasodilatation. 
Adrenaline infusion during propranolol medication caused an increase in 
vascular resistance in the forearm and an increase in the diastolic blood pres­
sure. A plausible explanation is that propranolol had blocked the arteriolar 
02 -receptors, so that adrenaline caused vasoconstriction by stimulating the 
available α-receptors (Johnsson 1975). Vasoconstriction causes an increase 
in total peripheral resistance, resulting in an increase in blood pressure. The 
pulse pressure which increased after adrenaline in the placebo studies was 
essentially unchanged after adrenaline in combination with propranolol. This 
can be explained by blockade of cardiac /3-receptors. The development of 
bradycardia is explained by stimulation of the baroreceptors due to the rise 
of the arterial blood pressure (Lloyd-Mostyn and Oram 1975, Johnsson 1975). 
Adrenaline infusion during metoprolol medication caused a slight decrease 
in vascular resistance in the forearm. Thus the vasodilator effect of adrenaline 
partly persisted during metoprolol medication The diastolic pressure did not 
increase. The probable explanation is that metoprolol has a much less pro­
nounced affinity than propranolol for the ^-receptors . Adrenaline infusion 
caused only a slight increase in systolic pressure and had no effect on diastolic 
pressure, pulse pressure and heart rate. The effect on heart rate and pulse 
pressure which adrenaline normally produces via direct stimulation of cardiac 
^-receptors on the one hand and via the baroreceptor reflex on the other, 
appeared largely to have been blocked by metoprolol. 
It has been established that coronary vessels like muscle vessels are supplied 
with a- and β
г
 -adrenergic receptors and that the constrictor response to 
adrenaline can be unmasked by propranolol (McRaven et al. 1971, Mark et 
al. 1972, Yasue et al. 1974). It seems probable then that adrenaline infusion 
during propranolol treatment causes a decrease of the coronary circulation 
by a direct influence on coronary vessels on the one hand and via the un­
favourable haemodynamic changes on the other. This might explain the com­
plaints of a pressing sensation on the chest in some patients during adrenaline 
infusion in the propranolol period. However, no pathological ECG changes 
were recorded during these adrenaline experiments. 
Thus adrenaline caused very different haemodynamic changes during treat­
ment with propranolol and metoprolol; the difference was apparently due to 
the different affinity for ßi -adrenoceptors. These findings essentially agree 
with the observations of Brick et al. (1968) and Johnsson (1975), who 
studied effects of adrenaline in healthy subjects after a single dose of non-
selective and selective β
λ
 -adrenoceptor blockers. Even after long-term 
medication with propranolol and metoprolol in conventional doses in 
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hypertensive patients, the haemodynamic changes induced by adrenaline 
proved t o be less unfavourable during metoprolol medication. This raises the 
question whether a β ¡ -selective blocker should be preferred to a non-selective 
ß-Ыоскеі in the treatment of hypertension. 
During emotional stress, endogenous adrenaline release increases (Levi 1972), 
and the vascular resistance in muscle decreases (Brod et al. 1976). Moreover 
it has been shown that the increase of the blood flow in the forearm in 
response to emotional stress is reduced or abolished during non-selective 
j3-blockade (Glover et al. 1962). Therefore, it is probable that the adrenaline 
release caused by such conditions as emotion, angina pectoris and hypo-
glycaemia, is comparable t o the adrenaline infusion in the present study. If 
this is true, then such stress is bound to result in a significant increase in 
blood pressure during propranolol medication. 
During hypoglycaemia after propranolol administration, a significant increase 
in diastolic pressure and bradycardia have been observed (Lloyd-Mostyn and 
Oram 1975). In four hypertensive patients treated only with propranolol, a 
conspicuous increase in blood pressure was observed during a stressful exami­
nation in hospital; this was associated with a significant increase in peripheral 
resistance (Tarazi and Dustan 1972). Another report (Blum et al. 1975) has 
mentioned a paradoxical increase in blood pressure observed during pro­
pranolol treatment in psychiatric patients in whom catecholamine release 
appeared to be increased. In these patients the untoward increase in blood 
pressure was successfully treated with a-blockers. These clinical situations 
would seem to be analogous to the present observations during infusion of 
adrenaline. The results, therefore, appear to have clinical implications and 
argue in favour of the use of β^ -selective blockers rather than non-selective 
/3-blockers in the treatment of hypertensive patients. 
5. Summary 
A double blind cross-over trial of the non-selective j8-blocker propranolol 
and the β ι -selective blocker metoprolol was carried out in eight hypertensive 
patients. At the end of each four-week period of medication, the haemo­
dynamic effects of adrenaline infusion were studied. Adrenaline infusion 
during propranolol medication caused a marked increase in systolic and 
diastolic blood pressure. The blood flow in the forearm was unchanged and 
the calculated vascular resistance in the forearm showed a marked increase. 
Adrenaline infusion during metoprolol medication caused a less marked 
increase in systolic blood pressure, and the diastolic pressure remained 
unchanged. Blood flow in the forearm increased and the vascular resistance 
in the forearm tended to decrease. The haemodynamic effects of adrenaline 
infusion after 6 months of treatment were similar to those registered after 
4 weeks. Thus, adrenaline infusion caused different haemodynamic effects 
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during non-selective /3-bIockade with propranolol and during β, -selective 
blockade with metoprolol. It seems probable that the adrenaline infusion 
test is comparable with adrenaline release during stress situations and the 
results may indicate that a β ι -selective blocker is to be preferred to a non­
selective one as a therapeutic agent in the treatment of hypertension. 
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CHAPTER 6 
Effects of propranolol and metoprolol on haemodynamic and 
respiratory variables and on perceived exertion during 
exercise in hypertensive patients 
6.1. Introduction 
During muscular exercise the plasma catecholamine concentration increases 
as a result of the increased activity of the sympathetic nervous system and 
the adrenal medulla (Vendsalu 1960; Davies et al. 1974; Galbo et al. 1975). 
This increased adrenergic activity plays an important role in the adaptation 
of the circulatory system to exercise (Bevegird and Shephard 1967). The 
β ! -selective blockers, as well as the non-selective 0-blockers, reduce the heart 
rate, the cardiac output and the blood pressure during exercise. (Gumming 
and Carr 1967, Johnsson et al. 1969, Ablad et al. 1976, Reybrouck et al. 
1977). It is possible, however, that the haemodynamic changes induced by 
β ι -selective and non-selective ß-blockers differ during exercise. For example, 
a non-selective /З-Ыоскег, such as propranolol, would be expected to diminish 
the vasodilatation in exercising muscle by blocking the arteriolar 02 -recep­
tors. This would then affect the blood pressure. On the other hand, a much 
smaller effect on the peripheral resistance would be expected from a β ι -selec­
tive blocker such as metoprolol. (Johnsson 1975). 
Further, a non-selective ¿¡-blocker might partly inhibit the bronchodilatation 
that occurs during exercise, by blocking the bronchiolar /З2 -receptors. A 
β ι -selective blocker, on the other hand, would not block this bronchodilata­
tion. (Johnsson et al. 1975a, Tivenius 1976). 
During treatment with propranolol some patients complain of fatigue, 
muscle weakness and aggravation of claudication (Zacharias 1976, Kellaway 
1976). These side effects may be related to the supposed effects on broncho-
dilatation and vasodilatation during exercise. If the two types of ß-blockers 
do produce different effects in this respect, exercise might be better tolerated 
during metoprolol treatment. 
To test these hypotheses, we investigated the effects of a β] -selective and a 
non-selective /3-blocker on haemodynamic and respiratory variables and on 
perceived exertion during exercise in hypertensive patients. During this 
study only non-invasive methods were used, in order to avoid stressful stimuli. 
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6.2. Patients and methods 
6.2.1. Patients 
The study comprised eight males with untreated essential hypertension, 
without demonstrable cardiac or pulmonary disease. These patients are 
described in detail in chapter 4. 
6.2.2. Design of the study 
Propranolol (80 mg thrice daily) and metoprolol (100 mg thrice daily) were 
compared with each other and with placebo in a double blind cross-over 
study, which is described in detail in chapter 4. There were four consecutive 
periods of medication, each lasting four weeks: placebo, /3-blocker, placebo, 
¿-blocker. The active agents were given in randomized order. At the end of 
each four-week period the same set of investigations (see below) was per-
formed. After this cross-over study 7 patients continued treatment with a 
/3-blocker in the same dose: 5 preferred metoprolol and 2 propranolol. After 
6 months of treatment these investigations were repeated. 
The investigations were carried out in a room with a constant temperature of 
190C, starting at 09.00 a.m., two hours after ingestion of the morning dose. 
The patients were asked to take a light breakfast without coffee and to 
abstain from smoking. To begin with, blood pressure and heart rate were 
measured at rest. Further blood samples were taken for chemical analysis, 
such as plasma level of the ^-blocker. The results of this part of the study are 
presented in chapter 4. Next, the effects of an adrenaline infusion on blood 
pressure, heart rate and blood flow in the forearm were measured. The 
results of this part of the investigation are presented in chapter 5. The exer-
cise test started at 10.30 a.m., a good half hour after stopping the adrenaline 
infusion. Haemodynamic and respiratory studies were performed during 
moderate exercise. 
6.2.3. Exercise test 
The schedule of the investigations during exercise is presented in figure 6.1. 
Exercise was performed in the seated position on a bicycle ergometer (LodeR ), 
with a pedalling rate of 60 cycles per minute. Before the start of the cross-
over study an exercise test was done to check whether the load of 1.5 W/ 
kg body weight represented a 'moderate' level of exercise. For this study 
'moderate exercise' was arbitrarily defined as exercise giving a heart rate 
between the 120 and 150 beats per minute. The load of 1.5 W/kg was too 
heavy for one of our eight patients and a load of 1 W/kg body weight was 
therefore chosen for him. This load was built up within two minutes by 
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Figure 6.1. Schedule of the investigations during exercise. 
increments of 0.5 W/kg and it was then maintained for 13 minutes. Measure­
ments were performed during steady-state exercise. 
6.2.4. Respiratory and haemodynamic variables 
The expiratory peak flow rate (maximum value of 3 observations) was mea­
sured before and after 6 minutes of exercise with the aid of a Wright peak 
flow meter. After 7 minutes of exercise measurements were started for the 
determination of O2 consumption ( V Q , )> ^^b production (VQQ ) respira­
tory frequency (f) and tidal volume (VT), as described in paragraph 3.2.3. 
The cardiac output was measured indirectly employing Fick's principle for 
C 0 2 , as described in chapter 3. The arteriovenous O2 content difference was 
calculated by dividing the 0 2 consumption by the cardiac output. 
An electrocardiogram was recorded every minute. The blood pressure was 
measured non-invasively with the Physiometrics SRII apparatus. This device 
detects Korotkoff sounds by means of a microphone, which is placed under 
a rigid cuff. The low-frequency vibrations (16—33 Hz) of the sounds are used 
as signals and recorded on a circular graduated disc. Similar techniques have 
been proved to yield reliable blood pressure recordings during submaximal 
exercise (Mastropaolo et al. 1964; Sime et al. 1975). 
We investigated the reproducibility of blood pressure measurements with the 
Physiometrics SRII in 21 subjects with 74 duplicate observations during 
consecutive exercise tests at a submaximal load. The standard error of a 
single observation (formula 16, paragraph 3.2.5) of the systolic pressure 
amounted 9.4 mm Hg at a mean value of 190 mm Hg (range 120—250). The 
standard error of a single observation of the diastolic pressure was 4.6 mm 
Hg at a mean value of 90 mm Hg (range 58—118). These precisions agree 
with the observations of Sime et al. (1975). 
TIME ' i n i n u t · ! ' 
- 3 0 
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The recorded blood pressure and heart rate values were the means of two mea­
surements after 7 and 9 minutes of exercise. Mean arterial pressure (MAP) 
was calculated by addition of 1/3 of the pulse pressure to the diastolic pres­
sure. The total peripheral resistance was calculated by dividing the MAP by 
the cardiac output and was expressed in arbitrary units (units). 
6.2.5. Perceived exertion 
For rating of perceived exertion the scale described by Borg (1970) was used. 
This R.P.E. scale consists of fifteen points from 6 to 20. Every second scale 
point is assigned a descriptive designation as follows: 7: very very light, 
9: very light, 11: fairly light, 13: somewhat hard, 15: hard, 17: very hard 
and 19: very very hard. The scores and descriptions were printed on a chart. 
After 4 and 14 minutes of exercise the patients were asked to indicate their 
score for perceived exertion. 
6.2.6. Statistics 
All results are presented as mean ± SEM. As the values appeared to be nor­
mally distributed, statistical analysis was carried out with Student's t-test 
for paired observations. The effects of the two 0-blockers were compared 
with each other and with the values obtained during the placebo period 
preceding the period of treatment with the j3-blocker in question. Correla­
tions were calculated according to Pearson. 
6.3. Results 
6.3.1. Results of the cross-over study, propranolol versus metoprolol 
The data from the four periods are presented in tables 6.1, 6.2 and 6.3. No 
significant differences were found between the values recorded in the two 
placebo periods. Propranolol and metoprolol reduced the blood pressure, 
heart rate and cardiac output during exercise equally (table 6.1). The stroke 
volume increased during (3-blockade, while peripheral resistance did not 
change. These haemodynamic changes in relation to the placebo values are 
graphically presented in figure 6.2. A tendency appears to exist for systolic 
pressure to decrease more during propranolol medication than during meto­
prolol treatment. The mixed venous C0 2 pressure (Русо ) increased during 
both types of j3-blockade, as did the veno-arterial 0 2 and CO2 gradients. The 
arterial CO2 pressure (Paco, ) w a s slightly higher during treatment with 
metoprolol than during the placebo period. Neither ^-blocking agent caused 
significant differences in the O2 consumption (VQ ), CO2 production 
(VCo ), tidal volume (VT) or respiratory rate (f) (table 6.1). 
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Table 6.1. Respiratory and haemodynamic variabeles during exercise after 4 weeks of placebo followed by 4 weeks of 
^-blockade (mean ± SEM, η = 8) 
Cardiac output 
Heart rate 
Stroke volume 
Systolic pressure 
(l/min) 
(beats/min) 
(ml) 
(mm Hg) 
Mean arterial pressure ( m m H g ) 
Diastolic pressure (mm Hg) 
Total peripheral resistance (units) 
P
vCO, 
2 
P
aC0 2 
C
v C 0 2
 — C
a C 0 2 
ÇaO, — C v 0 2 
V o 2 
^co2 
vT 
f 
(mm Hg) 
(mm Hg) 
(ml /100 ml) 
(ml /100 ml) 
(l /min) 
(l/min) 
(1) 
(breaths/min) 
placebo 
13.4 ± 
130 ± 
105 ± 
204 ± 
132 ± 
97 ± 
10.1 ± 
66 ± 
37 ± 
11.8 ± 
12.1 ± 
1.62 ± 
1.58 ± 
2.2 ± 
21 ± 
0.7 
5 
7 
4 
1 
2 
0.6 
1 
2 
0.5 
0.4 
0.10 
0.11 
0.2 
3 
propranolol 
11.4 ± 
95 ± 
121 ± 
161 t 
113 Í 
89 i 
10.1 ± 
72 t 
38 ± 
13.6 ± 
14.3 ± 
1.63 ± 
1.54 ± 
2.4 ± 
19 ± 
0.6 
3 
7 
5 
2 
2 
0.5 
1 
1 
0.5 
0.8 
0.13 
0.10 
0.2 
2 
P* 
< 0.005 
< 0.001 
< 0.001 
< 0.001 
< 0.001 
< 0.02 
NS 
< 0.001 
NS 
< 0.001 
< 0.005 
NS 
NS 
NS 
NS 
placebo 
13.8 + 
127 ± 
110 ± 
197 ± 
130 ± 
96 ± 
9.5 ± 
65 -
36 ± 
11.8 ± 
12.0 ± 
1.65 ± 
1.64 ± 
2.6 ± 
20 ± 
0.7 
4 
6 
5 
3 
3 
0.4 
1 
2 
0.5 
0.3 
0.08 
0.10 
0.3 
3 
meloprolol 
11.7 ± 
94 ± 
125 ± 
1 6 8 ± 
1 1 3 ± 
86 ± 
9.8 ± 
72 <• 
39 ± 
13.4 ± 
13.9 t 
1.63 ± 
1.57 ± 
2.4 t 
19 ± 
0.6 
2 
8 
5 
2 
2 
0.4 
1 
1 
0.3 
0.4 
0.10 
0.10 
0.2 
2 
P! 
< 
< 
< 
< 
< 
< 
< 
< 
< 
< 
t* 
0.001 
0.001 
0.05 
0.001 
0.001 
0.01 
NS 
0.001 
0.05 
0.001 
0.005 
NS 
NS 
NS 
NS 
P*** 
NS 
NS 
NS 
0.05 < 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
p* propranolol versus placebo 
p** metoprolol versus placebo 
p*** metoprolol versus propranolol 
NS ρ > 0.10 
oo 
00 
Table 6.2. Expiratory Peak Flow Rate (PFR) at rest and during exercise after 4 weeks of placebo followed by 4 weeks of 
0-blockade. (mean ± SEM, η = 8). 
PFR at rest (1/min) 
PFR during exercise (1/min) 
Δ PFR (1/min) 
ρ exercise versus rest 
placebo 
5 6 3 ± 21 
5 9 2 + 18 
29 ± 7 
< 0.01 
propranolol 
540 + 20 
568 ± 20 
28 ± 10 
< 0.05 
P* 
< 0.05 
< 0.05 
NS 
placebo 
5 5 8 ± 16 
581 ± 18 
23 ± 4 
< 0.001 
metoprolol 
557 ± 16 
5 7 4 ± 15 
18 ± 6 
< 0.05 
p** 
NS 
NS 
NS 
p*** 
NS 
NS 
NS 
p* placebo versus propranolol 
p * * placebo versus metoprolol 
p * * * metoprolol versus propranolol 
NS ρ > 0.10 
Table 6 3 Ratings of Perceived Exertion (RPE) and heart rate at 4 and 14 minutes of 
exercise after 4 weeks of placebo followed by 4 weeks of /3 blockade (mean ± SEM, η = 8) 
placebo propranolol placebo metoprolol 
4 minutes 
RPE 
Heart rate 
14 minutes 
RPE 
Heart rate 
12 0 t 
121 ± 
13 4 ± 
134 ± 
0 5 
4 
0 4 
4 
12 0 ± 
90 » 
13 8 i 
97 ± 
0 6 
2 
0 4 
3 
11 5 ± 
118 ± 
12 5 ± 
131 ± 
0 8 
3 
0.4 
4 
12.0 + 
89 • 
13.1 ± 
Ô5± 
0 6 
2 
0 3 
2 
The expiratory peak flow rate (PFR) was in every period higher during exer-
cise than at rest (table 6.2) Propranolol reduced PFR at rest as well as during 
exercise. Metoprolol did not influence the PFR. However, no statistically 
significant differences were found between the values from the propranolol 
and metoprolol periods. Neither /J-blocking agent significantly influenced 
the exercise-induced increase in the peak flow rate (Δ PFR). 
Ratings of perceived exertion after 4 and 14 minutes of exercise and the 
simultaneously recorded heart rates are presented in table 6.3. Heart rate 
was clearly decreased during (3-blockade (p < 0.001). Neither propranolol 
nor metoprolol significantly influenced the RPE scores (sign-test). 
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Figure 6 2 Changes of haemodynamic variables during exercise after 4 weeks of β blockade 
compared to placebo values 
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Table 6.4. Respiratory and haemodynamic variables during exercise after 4 weeks and 6 months of treatment with metoprolol 
compared to placebo values (mean ± SEM, η = 5) 
Cardiac output 
Heart rate 
Stroke volume 
Mean arterial pressure 
(1/min) 
(beats/min) 
(ml) 
(mm Hg) 
Total peripheral resistance (units) 
PvCO, 
Р
а С О , 
C
v C O , — C a C O j 
C
a 0 2
 — C
v 0 2 
(mm Hg) 
(mm Hg) 
(ml/100 ml) 
(ml/100 ml) 
PLACEBO 
13.4 ± 1.0 
128 ± 7 
1 0 6 ± 10 
130 ± 4 
9.9 ± 0.5 
64 ± 2 
35 ± 2 
11.9 ± 0.7 
11.7 ± 0.5 
4 weeks 
11.2 ± 0.9 
9 3 ± 3 
1 2 2 ± 12 
112 ± 3 
10.1 ± 0.6 
71 ± 2 
38 ± 2 
13.2 ± 0.8 
13.4 ± 0.3 
METOPROLOL 
P* 
< 0.02 
< 0.01 
NS 
< 0.01 
NS 
< 0.01 
< 0.05 
< 0.05 
< 0.05 
6 months 
12.2 ± 0.8 
95 ± 2 
127 ± 9 
116 ± 1 
9.7 ± 0.6 
67 ± 1 
36 ± 2 
12.6 ± 0.5 
12.6 ± 0.05 
P** 
< 0.05 
< 0.01 
< 0.02 
< 0.01 
NS 
0.05 < ρ < 0.1 
NS 
< 0.05 
NS 
p*** 
0.05 < 
NS 
NS 
NS 
NS 
< 0.05 
NS 
0.05 < 
0.05 < 
Ρ < 
Ρ < 
Ρ < 
0.1 
0.1 
0.1 
ρ* metoprolol versus placebo 
ρ** metoprolol versus placebo 
p*** metoprolol 4 weeks versus metoprolol 6 months 
NS ρ > 0.10 
During the metoprolol studies the percentage decrease in heart rate compared 
to the placebo values was significantly correlated to the logarithm of the 
plasma metoprolol level (r = 0.79, ρ < 0.02). No other significant relation­
ships were found between the haemodynamic changes and the plasma levels 
of the β-blockers. 
6.3.2. Results after 6 months of ß-blockade 
The haemodynamic variables after 6 months of metoprolol medication in 
5 patients were comparable to those registered after 4 weeks of metoprolol 
treatment (table 6.4). The cardiac output after 6 months was possibly slightly 
higher than after 4 weeks of treatment. The P ^ o w a s lower after 6 months 
than after 4 weeks. As Paco2 did not change, the same tendency was also 
found for the venoarterial CO2 and O2 differences. The other respiratory 
variables and the RPE scores were not changed after 6 months' treatment 
with metoprolol. The measurements in the two patients after 6 months of 
propranolol medication showed comparable results to those registered after 
4 weeks of treatment. These values from only two patients have not been 
analyzed statistically. 
6.4. Discussion 
The doses of the two /3-blockers used in this study induced the same reduc-
tion of heart rate during exercise. This finding is in agreement with previous 
results (Johnsson et al. 1975b, Davidson et al. 1976). The drugs were given 
during a four-week period, which is sufficiently long for evaluation of the 
antihypertensive effect of ß-blockers (Zacharias and Cowen 1970, Hansson 
et al. 1974). Our results are in agreement with the findings in another study, 
which showed that propranolol and metoprolol reduce the blood pressure 
during exercise equally (Davidson et al. 1976). 
Increased sympathetic activity plays an important role in the adaptation of 
the circulation during exercise. (Bevegârd and Shephard 1967). ¿-Blockers 
decrease the heart rate and cardiac output during exercise. The β ι -selective 
metoprolol induced the same changes of heart rate, cardiac output and 
stroke volume as the non-selective ^-blocker propranolol. This was to be 
expected, because metoprolol and propranolol both block the cardiac adreno-
receptors. However, the remarkable finding was that the two /J-blockers 
reduced the blood pressure equally. There was apparently no difference in 
the effect of the two drugs on the peripheral resistance during exercise. In 
fact, the peripheral resistance was not influenced at all. 
During exercise the total peripheral resistance decreases by vasodilatation in 
active muscles, which is thought to be induced by a local mechanism (Beveglrd 
and Shephard, 1967). In other parts of the body, e.g. in the "non-active" 
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muscles, a reflex vasoconstriction occurs (Bevegârd and Shephard 1967). Up 
to now it was not clear what part vascular ßi -receptors play in the vascular 
adaptation during exercise. It has been established that propranolol blocks 
the vascular )32 -receptors for circulating catecholamines, whereas metoprolol 
has a much less pronounced effect (Johnsson 1975c, chapter 5). The fact, 
that neither the ^,-selective metoprolol nor the nonselective propranolol 
influenced the total peripheral resistance, shows that stimulation of the 
vascular 02 -receptors does not play an important part in the adaptation of 
the circulation i.e. in vasodilatation during steady-state exercise. 
During exercise bronchodilatation occurs; this may be induced by the 
increased sympathetic tone (Lefcoe 1969). A consequence of this is the 
increase in the expiratory peak flow rate (APFR) during exercise, as recorded 
in this study. Propranolol reduced the PFR at rest and during exercise, while 
metoprolol had hardly any influence. Analogous results were found after 
administration of propranolol and the ^ -selective practolol (Kumana et al. 
1974). These observations are probably related to the fact that metoprolol 
has a much less pronounced affinity for the bronchiolar 02 -receptors than 
propranolol (Johnsson et al. 1975a, Tivenius 1976). However, the proprano-
lol-induced reduction of PFR does not seem to be of functional significance 
because the ventilation was not influenced. After all, asthmatic patients 
ventilate during exercise with a smaller tidal volume and faster respiratory 
rate (Haynes et al. 1976). The increase of the PFR during exercise was not 
influenced by propranolol or by metoprolol. It therefore seems probable that 
this bronchodilatation during moderate exercise is not mediated via stimula-
tion of the bronchiolar 02 -receptors, but via some other mechanism. 
The 0 2 consumption and the CO2 production were not influenced by the 
ß-blocking agents. There was an increase in the veno-arterial O2 and CO2 
difference, which is related to the decreased cardiac output and decreased 
blood flow through the body. The blood is utilized more intensively as a 
transport medium during 0-blockade. It is not surprising that propranolol 
sometimes causes aggravation of claudication (Zacharias 1976) in patients 
with peripheral atherosclerosis as a result of the sluggish blood flow and 
decrease of O2 tension in active muscles. Since metoprolol and propranolol 
influence the circulation during exercise equally, this adverse effect was to 
be expected during metoprolol treatment also. Other side effects, such as 
fatigue and muscle weakness (Zacharias 1976, Kellaway 1976), may be 
caused by this decreased blood flow in muscle tissue. 
The heart rate during exercise is often used as a measure of the relative load 
(Holmgren 1956). Borg (1970) has so chosen the scores of his RPE scale that 
when multiplied by ten they represent on the average the heart rate. This 
relationship was also seen in our patients during the placebo periods, but was 
lacking during 0-blockade (table 6.3). Neither 0-blocker influenced the RPE 
scores. This suggests that this moderate exercise was not perceived as being 
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heavier during ß-blockade. On the other hand, this observation supports the 
concept that other factors besides heart rate influence perceived exertion 
(Ekblom and Goldbarg 1971, Noble et al. 1973). In any case, the relationship 
between heart rate and perceived exertion appears to be disconnected by 
/3-blockade (Ekblom and Goldbarg 1971). It should be noted, however, that 
our subjects could know that they were performing the same load at each 
exercise test, so that not to much value has to be attached to our findings in 
this respect. 
The results after 6 months of treatment with metoprolol were not essentially 
different from those after 4 weeks of medication. Only the cardiac output 
showed a tendency to return to the initial value of the placebo period. This 
effect of long-term j3-blocker medication is well known (Tarazi and Dustan 
1972, Atterhög et al. 1977). However, no decrease in the total peripheral 
resistance was seen even after 6 months. It may thus be postulated that the 
antihypertensive effect is still caused by decrease of the cardiac output. 
As far as their practical use is concerned, this study suggests no advantage for 
either of these j3-blocking drugs. The investigations of the haemodynamic 
effects of adrenaline, however, argue in favour of the use of β j -selective 
blockers rather than nonselective j3-blockers in the treatment of hypertensive 
patients (chapter 5). From a physiological point of view, this study suggest 
that the role for the vascular and bronchiolar 02 -adreno-receptors is only of 
minor importance in the adaptation of the circulation and ventilation to 
steady-state exercise. 
6.5. Summary 
A double blind cross-over trial of the non-selective /3-blocker propranolol and 
the β ι -selective blocker metoprolol was carried out in eight hypertensive 
patients. At the end of each four-week period of medication haemodynamic 
and respiratory variables and perceived exertion were studied during moderate 
exercise. The two ß-blockers reduced heart rate, cardiac output and blood 
pressure equally, whereas the stroke volume increased. Total peripheral 
resistance did not change. During exercise the expiratory peak flow rate 
(PFR) increased equally in every period. However, the PFR at rest, as well as 
during exercise, was reduced by propranolol, while metoprolol had no such 
influence. Neither of the ß-blockers changed O2 consumption, C02 produc-
tion, tidal volume or respiratory rate. Nor, did they influence perceived 
exertion. The haemodynamic effects of exercise after 6 months of treatment 
were similar to those registered after 4 weeks. These results suggest that the 
arteriolar and bronchiolar /32 -receptors do not play a major role in the adapta-
tion of the circulation and ventilation during exercise. As far as their practical 
use as antihypertensive agents is concerned, this part of the study shows no 
advantage of either of these /3-blockers. 
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Summary 
In recent years 0-adrenoceptor blocking drugs have been frequently used in 
the treatment of hypertension. The development of these drugs was based on 
the adrenoreceptor theory of Ahlquist. Chapter 1 gives a summary of this 
hypothesis and of the later refinements, such as the distinction of the β -recep­
tors into two subtypes, β ι and 02. 
The mechanism via which /3-blockers lower the blood pressure has not yet 
been completely elucidated. Possible explanations are, among others, the 
lowering of the cardiac output and the suppression of plasma renin activity. 
It remains debatable to what extent the action of ß-blockers on the plasma 
renin activity is of importance for the lowering of the blood pressure. 
Propranolol which blocks both β ι and β^ -receptors has become the most 
used |3-blocking agent. A side effect of this non-selective |3-blockade may be 
bronchial obstruction, caused by blocking of the bronchiolar β^ -receptors. The 
administration of β y -selective blockers, which also exert a hypotensive action, 
diminishes the incidence of this undesirable effect. 
As a more essential advantage it has been claimed that during treatment with 
β ! -selective drugs an increase of the plasma adrenaline level does not cause a 
vasoconstriction in muscle as it is supposed to do during non-selective 
/3-blockade. This problem has been investigated in normal subjects after 
intravenous injection of propranolol or the β j-selective blocker metoprolol 
(Johnson 1975); during an adrenaline infusion a marked increase in diastolic 
pressure and in peripheral resistance was recorded in the studies with pro­
pranolol, whereas the vasodilator effect of adrenaline remained largely intact 
in the metoprolol studies. 
However, the haemodynamic effects of one single dose are not similar to the 
effects of long-term medication with ^-blockers. Therefore, it seemed relevant 
to investigate the haemodynamic effects of raised adrenergic activity during 
long-term medication with both types of/3-blockers in hypertensive patients. 
For the study of the haemodynamic effects of exercise a non-invasive method 
for measuring the cardiac output had to be instituted. Since the development 
of rapid C0 2 analyzers it has been possible in the last 2 decades to measure 
the cardiac output indirectly according to Fick's principle for C 0 2 . The 
literature on this method was studied (chapter 2). 
For the indirect application of Fick's principle for CO2 the C0 2 tensions in 
mixed venous and arterial blood has to be assessed by breathing manoeuvres 
(paragraph 2.2.). 
For the determination of the C0 2 tension in mixed venous blood (Русо ) 
the CO2 rebreathing procedure according to the plateau method of Collier 
(1956) is to be preferred (paragraph 2.3). It was shown, however, that during 
the equilibration phase of this C0 2 rebreathing method the measured CO2 
tension plateau was higher than the simultaneously directly measured C0 2 
tension in blood. There is no sure explanation forthcoming for this alveolo-
capillary CO2 tension gradient. 
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The arterial C02 tension (Paco2 ) during exercise can be indirectly approached 
by substituting in the formula of Bohr estimated values for the physiological 
dead space (paragraph 2.4.). 
The COj concentrations, which must be entered in Pick's formula, can be 
obtained from theCOj tensions via a CO2 dissociation curve (paragraph 2.5). 
From our calculations it has turned out that the various CO2 dissociation 
curves from the literature differ from each other to such a degree that consi-
derable divergencies exist in the calculation of the cardiac output. By apply-
ing a calculation programma for the CO2 dissociation curve, we were able to 
work out the influences of changes in temperature, O2 saturation, haemo-
globin concentration and acid-base balance on the venoarterial CO2 concen-
tration gradient and on the cardiac output. 
After, on the basis of the data in the literature, scrutinizing the extent to 
which these variables change during exercise, it seemed desirable for the con-
version of CO2 tension to CO2 concentration to make use of a calculation 
programme in which corrections are made for the expected changes of pH 
and base excess during exercise (paragraph 2.6). 
Before applying this cardiac output determination some aspects of these 
measurements in our hands were investigated, such as the validity and repro-
ducibility during exercise (chapter 3). Also we went into the question 
whether the assumed values for pH and base excess were adequate for the 
calculation of the venoarterial CO2 concentration gradient. 
The validity of this cardiac output determination was examined by compar-
ing the results with the data in the literature. The cardiac output (Qpiat)> 
calculated via the uncorrected CO2 tension plateau, turned out to be too low. 
However, the cardiac output (Qy), calculated via the CO2 tension plateau 
after correction for the alveolocapillary CO2 tension gradient, showed a 
strikingly good agreement with these data from the literature. Thus, the most 
valid calculation of the cardiac output was obtained if the CO2 tension in 
mixed venous blood was approximated as well as possible. 
The acid-base balance was studied during exercise in order to assess the influ-
ence of pH and base excess on the calculation of the venoarterial CO2 con-
centration gradient. The CO2 concentration gradients and corresponding 
cardiac output values, calculated by applying the measured pH and base 
excess, showed only slight differences compared to the values which were 
calculated using the assumed pH and base excess. The calculation programme 
for the CO2 dissociation as applied in this study (formula 15) was found to 
be reasonably adequate, certainly during light and moderate exercise (para-
graph 3.3.2.). 
The reproducibility of this cardiac output measurement was investigated by 
repetition of the exercise test. The measurement during exercise was found 
to be satisfactorily reproducible with a relative standard error of a single 
observation of about 4% (paragraph 3.3.3.). The reproducibility using this 
indirect method was found to be as good as that of invasive measurements 
(paragraph 3.4). 
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After this cardiac output measurement had been found to be valid and reli­
able during exercise, this method was employed at the study of the haemo-
dynamic effects of j3-blockade. 
For the comparative study of the effects of non-selective ^-blockade with 
propranolol and of β ] -selective blockade with metoprolol a double blind 
cross-over trial was carried out in eight hypertensive patients. There were 4 
consecutive periods: placebo-drug-placebo-drug. At the end of each four-
week period of medication the same investigations were performed. After 
this cross-over study 5 patients continued the treatment with metoprolol 
and 2 patients the medication with propranolol. After 6 months the investi­
gations were repeated. 
The effects of propranolol and metoprolol on blood pressure at rest and 
plasma renin activity (PRA) are described in chapter 4. 
After 4 weeks of medication propranolol and metoprolol gave approximately 
the same reduction of blood pressure and heart rate. Propranolol caused a 
decrease of PRA, whereas metoprolol had no significant effect on PRA. 
Neither of the two j3-blockers influenced other laboratory values, including 
plasma aldosterone, or bodyweight. The decrease of the diastolic pressure 
during metoprolol medication was significantly correlated to the plasma 
level of the drug. 
In 5 patients who continued metoprolol treatment, PRA was suppressed 
after 6 months. 
The observations that the two ^-blocking agents reduced blood pressure 
equally without having an equal effect on PRA suggests that the antihyper­
tensive action of ß-blockers is mainly due to other mechanisms than suppres-
sion of PRA. 
The haemodynamic effects of adrenaline during treatment with propranolol 
and metoprolol are described in chapter 5. 
After 4 weeks of treatment with propranolol adrenaline infusion caused a 
marked increase in systolic and diastolic blood pressure. The blood flow in 
the forearm was unchanged and the calculated vascular resistance in the 
forearm showed a marked increase. Adrenaline infusion during metoprolol 
medication caused a less marked increase in systolic blood pressure, and the 
diastolic pressure remained unchanged. Blood flow in the forearm increased 
and the vascular resistance in the forearm tended to decrease. 
The haemodynamic effects of adrenaline infusion after 6 months of treat-
ment were similar to those registered after 4 weeks. 
Thus, adrenaline infusion caused different haemodynamic effects during non-
selective 0-blockade with propranolol and during β,-selective blockade with 
metoprolol. It seems probable that the adrenaline infusion test is comparable 
with adrenaline release during stress situations and the results may indicate 
that a β ι -selective blocker is to be preferred to a non-selective one as a 
therapeutic agent in the treatment of hypertension. 
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The effects of propranolol and metoprolol on haemodynamic and respiratory 
variables and on perceived exertion during exercise are described in chapter 6. 
At the end of each four-week period of medication haemodynamic and respi-
ratory variables and perceived exertion were studied during moderate exercise. 
The two j3-blockers reduced heart rate, cardiac output and blood pressure 
equally, whereas the stroke volume increased. Total peripheral resistance did 
not change. During exercise the expiratory peak flow rate (PFR) increased 
equally in every period. However, the PFR at rest, as well as during exercise, 
was reduced by propranolol, while metoprolol had no such influence. Neither 
of the ^-blockers changed 0 2 consumption, CO2 production, tidal volume or 
respiratory rate. Nor, did they influence perceived exertion. 
The haemodynamic effects of exercise after 6 months of treatment were 
similar to those registered after 4 weeks. 
These results suggest that the arteriolar and bronchiolar 02 -receptors do not 
play a major role in the adaptation of the circulation and ventilation during 
exercise. As far as their practical use as antihypertensive agents is concerned, 
this part of the study shows no advantage of either of these /?-blockers. 
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STELLINGEN 
I 
Bij de hypertensiebehandeling verdienen ßi -selectieve blokkeerders de voor-
keur boven niet-selectieve /J-blokkeerders op grond van hun effecten op de 
bloedsomloop. 
Dit proefschrift 
II 
De vasculaire 02 -receptoren spelen geen rol van betekenis bij de adaptatie van 
de circulatie tijdens dynamische steady-state inspanning. 
Dit proefschrift 
III 
De bepaling van het hartminuutvolume volgens het indirekte principe van 
Fick voor CO2 is tijdens inspanning valide en betrouwbaar, mits rekening 
gehouden wordt met de effecten van de verstoring van het zuur-base even-
wicht op de CO2 dissociatiecurve. 
Dit proefschrift 
IV 
De effecten van antihypertensiva op de bloeddruk dienen niet alleen in rust, 
doch ook tijdens inspanning en stress-toestanden beoordeeld te worden. 
V 
Bij patiënten met een ernstige, progressieve jichtarthritis dient, zeker indien 
de eerste symptomen opgetreden zijn onder de leeftijd van 30 jaar, het 
bestaan van een enzymdeficiëntie overwogen te worden. 
C. L. A. van Herwaarden, J . K. van der Korst , Λ. M. T. Boerbooms, 
C. H . M . M , de Bruyn and T. L. Oei. N e t h . J . Med. 19, 272 ( 1 9 7 6 ) 
VI 
Het is van belang onder de familieleden van een patiënt met jicht ten gevolge 
van een partiële HG-PRT (hypoxanthine guanine-phosphoribosyltransferase) 
deficiëntie een onderzoek in te stellen naar draagsters en lijders. 
C. L. A. van Herwaarden, J. K. van der Korst, A. M. T. Boerbooms, 
C. H.M.M, de Bruyn and T. L. Oei. Neth. J. Med. 19, 272 (1976) 
VII 
Hepatosplenomegalie en leverfunctiestoornissen kunnen voorkomen als een 
manifestatie van een hypernephroom zonder metastasen. 
P.N. Walsh and J .M. Kissane. Arch. Intern. Med. 122, 214 (1968) 
Eigen waarneming 
VIII 
Bij de chirurgische behandeling van de pulmonale echinococcuskyste kan 
men bij een ongecompliceerde of gesloten kyste volstaan met het enucleëren 
van de endokyste of parasiet; bij de gecompliceerde of open kyste dient men 
bovendien de perikyste, gevormd door de gastheer, te reseceron. 
L. K. Lacquet, C. L. A. van Herwaarden, Th. Sparrius, C. M. Jongerius. 
Tijdschrift voor Geneeskunde 11,601 (1977) 
IX 
Planigrafisch onderzoek van pulmonale afwijkingen dient bij voorkeur ver-
richt te worden bij patiënten in de verticale in plaats van in de horizontale 
positie. 
X 
Bij het voorschrijven van tetracyclines, zoals tetracycline en doxycycline, 
dient men de patiënt te adviseren de medicamenten met veel water en in een 
verticale houding in te nemen. 
R. H. B. Meyboom, Ned. T. Geneesk. 121, 1770 (1977) 
XI 
Bij sollicitaties wordt de zorgvuldigheid van de selectie bevorderd door géén 
referenties in te winnen. 
Nijmegen C. L. A. van Herwaarden 


